Skip to : [Content] [Navigation]
 

MDDI Page | Category Index

Medical Device & Diagnostic Industry
Articles by Category - Regulatory Affairs

2005 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 | 1982 | 1981 | 1980 | 1979

Note: To order an article reprint, or back issue, please contact the Canon Bookstore at 310/445-3770, or send E-mail to bookstore@devicelink.com. For faster service, fax your request, along with your telephone number, to 310/445-4259. Volume discounts are available.

2005

Return to the top of the page

2002

Return to the top of the page

2001

Return to the top of the page

2000

Return to the top of the page

1999

Return to the top of the page

1998

Return to the top of the page

1997

Return to the top of the page

1996

Return to the top of the page

1995

  • 510(k) Changes: FDA Tries Again, Robert L. Sheridan (MDDI, Dec 1995, p. 46). Keywords: Device Modifications.
  • Human Factors Assume Greater Role in Device Review, Michael E. Wiklund (MDDI, Dec 1995, p. 28). Keywords: Human Factors.
  • (News) Device Groups Reach Consensus on FDA Reform Legislation (MDDI, Dec 1995, p. 12). Keywords: FDA Reform.
  • FDA Regulation of Medical Device Reuse, Jonathan S. Kahan (MDDI, Nov 1995, p. 62). Keywords: Medical Device Reuse.
  • (Interview) Speeding toward a Third-Party Future?, Susan Alpert (MDDI, Nov 1995, p. 28). Keywords: Review Process.
  • (News) Spring Release Expected for Revised GMP and Guidances (MDDI, Nov 1995, p. 12). Keyword: GMPs.
  • (Washington Wrap-Up) Pilot Reviews Elicit Skepticism, James G. Dickinson (MDDI, Oct 1995, p. 51). Keywords: Product Approvals.
  • (Washington Wrap-Up) User Fees Shorten Drug Review Times, James G. Dickinson (MDDI, Oct 1995, p. 50). Keywords: User Fees.
  • Misguided Export Policy, Judd Gregg (MDDI, Oct 1995, p. 42). Keyword: Exports.
  • (News) AAMI Moving Forward with Certification Program (MDDI, Oct 1995, p. 18). Keyword: GMPs.
  • Do Bureaucracy and Innovation Mix?, John Bethune (MDDI, Oct 1995, p. 8). Keywords: Design Control.
  • Medical Device Regulatory Requirements for Electromagnetic Compatibility, Jonathan S. Kahan (MDDI, Sep 1995, p. 86). Keyword: EMC/EMI.
  • FDA's New GMP Working Draft: Industry's Last Chance for Comment, W. Fred Hooten (MDDI, Sep 1995, p. 72). Keyword: GMPs.
  • (Washington Wrap-Up) Agency Seeks Redesign of Electrode Lead-Wire Devices, James G. Dickinson (MDDI, Sep 1995, p. 56). Keywords: Performance Standards.
  • (Washington Wrap-Up) Advertisers Prefer FTC to FDA, James G. Dickinson (MDDI, Sep 1995, p. 55). Keyword: Marketing.
  • (Washington Wrap-Up) Gram Heads Senate Medical Technology Caucus, James G. Dickinson (MDDI, Sep 1995, p. 54). Keyword: Congress.
  • (Washington Wrap-Up) Wyden Bill Seeks to 'Improve and Advance' FDA, James G. Dickinson (MDDI, Sep 1995, p. 52). Keyword: Legislation.
  • (Washington Wrap-Up) HIMA Turns Up the Heat, James G. Dickinson (MDDI, Sep 1995, p. 52). Keywords: FDA Reform.
  • Third-Party Review: Great Ideas Need Time to Mature, John Bethune (MDDI, Sep 1995, p. 8). Keywords: Product Approval.
  • (Washington Wrap-Up) Third-Party 510(k) Reviews, James G. Dickinson (MDDI, Aug 1995, p. 46). Keywords: Product Approval.
  • (Washington Wrap-Up) HIMA: Abolish Most 510(k)s, James G. Dickinson (MDDI, Aug 1995, p. 46). Keywords: Product Approval.
  • Preamendment Class III Devices: The FDA Strategy, Charles H. Kyper (MDDI, Jul 1995, p. 100). Keyword: Reclassification.
  • (Washington Wrap-Up) FDA Suffers Historic Loss, James G. Dickinson (MDDI, Jul 1995, p. 40). Keyword: Labeling.
  • (Interview) Congress Is as Congress Does, Wayne Barlow (MDDI, Jul 1995, p. 28). Keywords: FDA Reform.
  • FDA Reform: Fact or Fiction?, Jonathan S. Kahan (MDDI, Jul 1995, p. 20). Keywords: FDA Reform.
  • (News) Device Community Struggles for Harmony on FDA Reform (MDDI, Jul 1995, p. 12). Keywords: FDA Reform.
  • (Washington Wrap-Up) Medical Devices for USP?, James G. Dickinson (MDDI, May 1995, p. 67). Keywords: Product Information.
  • (Washington Wrap-Up) FDA Looks at Symbols for Labeling, James G. Dickinson (MDDI, May 1995, p. 66). Keyword: Labeling.
  • (Washington Wrap-Up) HIMA's Ideas for Fixing FDA, James G. Dickinson (MDDI, May 1995, p. 64). Keywords: FDA Reform.
  • (Washington Wrap-Up) Relief for Device Exports, James G. Dickinson (MDDI, Apr 1995, p. 28). Keyword: Exports.
  • (News) AAMI Developing Certification Program for GMP Consultants (MDDI, Apr 1995, p. 10). Keyword: GMPs.
  • Should Regulations Be Undone, or Redone?, John Bethune (MDDI, Apr 1995, p. 8). Keywords: FDA Reform.
  • (Washington Wrap-Up) Unapproved Device Shipments--Pro and Con, James G. Dickinson (MDDI, Mar 1995, p. 44). Keyword: Exports.
  • (Washington Wrap-Up) Drug User Fees a Success, James G. Dickinson (MDDI, Mar 1995, p. 40). Keywords: User Fees.
  • (Guest Editorial) Reinventing the Environment for Innovation, William W. George (MDDI, Feb 1995, p. 24). Keywords: Regulatory Climate.
  • (News) Revised GMP Delayed Again (MDDI, Feb 1995, p. 10). Keyword: GMPs.
  • The Role of Labeling in the Compliant Use of Medical Devices, James R. Callan (MDDI, Jan 1995, p. 202). Keyword: Labeling.
  • FDA Criminal Prosecutions: New Trends and Old Problems, Jonathan S. Kahan (MDDI, Jan 1995, p. 101). Keyword: Enforcement.
  • (News) FDA Policy on Off-Label Training Fuels Debate (MDDI, Jan 1995, p. 14). Keyword: Labeling.
Return to the top of the page

1994

  • (Washington Wrap-Up) Petition Seeks Saline Implant Limits, James G. Dickinson (MDDI, Nov 1994, p. 32). Keywords: Product Restrictions.
  • (Washington Wrap-Up) Pedicle Screws for Class II for Two Uses Only, James G. Dickinson (MDDI, Nov 1994, p. 32). Keyword: Reclassification.
  • (Washington Wrap-Up) Hatch to the Rescue, James G. Dickinson (MDDI, Nov 1994, p. 28). Keyword: Legislation.
  • (Guest Editorial) Taxation without Representation: The Case against FDA User Fees, Thomas C. Thompson (MDDI, Nov 1994, p. 22). Keywords: User Fees.
  • Biocompatibility Concerns and Premarket Submissions, Jonathan S. Kahan (MDDI, Oct 1994, p. 94). Keyword: Biocompatibility.
  • (Washington Wrap-Up) Johnson Defends FDA's Experts, James G. Dickinson (MDDI, Oct 1994, p. 66). Keyword: Enforcement.
  • (Washington Wrap-Up) Unforeseen Downside to User Fees, James G. Dickinson (MDDI, Oct 1994, p. 66). Keywords: User Fees.
  • (Washington Wrap-Up) HIMA Buys User Fees--'Without Enthusiasm', James G. Dickinson (MDDI, Oct 1994, p. 64). Keywords: User Fees.
  • (Interview) Current Status of GMP Revisions Unveiled, W. Fred Hooten (MDDI, Oct 1994, p. 50). Keyword: GMPs.
  • (Guest Editorial) The Adverse Side Effects of FDA's Hearing Aid Prescriptions, Mead C. Killion (MDDI, Oct 1994, p. 42). Keyword: Advertising.
  • (Washington Wrap-Up) FDA's 'Secret' Warning Letters, James G. Dickinson (MDDI, Sep 1994, p. 39). Keywords: Freedom of Information.
  • (Washington Wrap-Up) Laerdal Wins: Judge Faults FDA Experts, James G. Dickinson (MDDI, Sep 1994, p. 38). Keyword: Enforcement.
  • (Washington Wrap-Up) FDA Eyes New Informed-Consent Regulations, James G. Dickinson (MDDI, Sep 1994, p. 36). Keywords: Clinical Investigations.
  • (Guest Editorial) Bad-Faith Reviews: The R S Medical Case, James R. Phelps (MDDI, Sep 1994, p. 30). Keyword: 510(k)s.
  • How to Prepare for (and Survive) an FDA Inspection, Jim Sandberg (MDDI, Aug 1994, p. 58). Keyword: Inspections.
  • 510(k)s for Sale, Bradley Merrill Thompson (MDDI, Aug 1994, p. 34). Keyword: 510(k)s.
  • (Washington Wrap-Up) FDA Moving Closer to Hearing Industry, James G. Dickinson (MDDI, Aug 1994, p. 30). Keyword: Advertising.
  • (Washington Wrap-Up) Case of the Late Warning Letter, James G. Dickinson (MDDI, Aug 1994, p. 30). Keywords: Warning Letters.
  • (Washington Wrap-Up) FDA Loses Customs Bond Seizure Case, James G. Dickinson (MDDI, Aug 1994, p. 28). Keyword: Exports.
  • An Inspector Calls, John Bethune (MDDI, Aug 1994, p. 8). Keyword: Inspections.
  • Managing Regulatory Submissions for Device Modifications (Revisited), Robert Sheridan (MDDI, Jul 1994, p. 36). Keywords: Device Modifications.
  • (Washington Wrap-Up) User Fees Make FDA Listen, James G. Dickinson (MDDI, Jul 1994, p. 30). Keywords: User Fees.
  • Washington Wrap-up: NMC in Trouble Again over Bloodlines Supply, James G. Dickinson (MDDI, Jun 1994, p. 48). Keywords: Washington Wrap-up.
  • Washington Wrap-up: Press Use of FDA Report Spurs Suit against Bard, James G. Dickinson (MDDI, Jun 1994, p. 48). Keywords: Washington Wrap-up.
  • (Washington Wrap-Up) NMC in Trouble Again over Bloodlines Supply, James G. Dickinson (MDDI, Jun 1994, p. 48). Keyword: Enforcement.
  • Washington Wrap-up: More Inforation Seen as Cost Curb, James G. Dickinson (MDDI, Jun 1994, p. 46). Keywords: Washington Wrap-up.
  • (Washington Wrap-Up) Component Suppliers under FDA Rule, James G. Dickinson (MDDI, Jun 1994, p. 44). Keyword: GMPs.
  • Washington Wrap-up: Component Suppliers under FDA Rule, James G. Dickinson (MDDI, Jun 1994, p. 44). Keywords: Washington Wrap-up.
  • Washington Wrap-up: FDA Reviewers Wasting Time?, James G. Dickinson (MDDI, Jun 1994, p. 44). Keywords: Washington Wrap-up.
  • (Interview) Medical Technology Caucus Rallies Congressional Support for Device Industry, Jim Ramstad (MDDI, Jun 1994, p. 38). Keyword: Congress.
  • A New Era for Clinical Studies of Medical Devices, C. Stephen Lawrence (MDDI, May 1994, p. 152). Keywords: Clinical Investigations.
  • Medical Device Labeling: Evaluating the Adequacy of Warnings and Instructions, Kenneth Ross (MDDI, May 1994, p. 148). Keyword: Labeling.
  • FDA's Revised GMP Regulation: The Road to Global Improvement?, Jonathan S. Kahan (MDDI, May 1994, p. 128). Keyword: GMPs.
  • Preparing for FDA's Postmarket Surveillance Requirements, Donald E. Segal (MDDI, May 1994, p. 76). Keywords: Postmarket Surveillance.
  • (Washington Wrap-Up) Intraocular Fluid, Promotional Material Seized, James G. Dickinson (MDDI, May 1994, p. 72). Keyword: Marketing.
  • (Washington Wrap-Up) FDA Civil Penalties, James G. Dickinson (MDDI, May 1994, p. 70). Keyword: Enforcement.
  • (Washington Wrap-Up) A Matter of 'Attitude Adjustment', James G. Dickinson (MDDI, May 1994, p. 66). Keywords: Government-Industry Cooperation.
  • (News) Consultants Stew over FDA Efforts to Regulate Them (MDDI, May 1994, p. 24). Keyword: GMPs.
  • Are You Scientifically Correct?, John Bethune (MDDI, May 1994, p. 10). Keyword: Science.
  • (Washington Wrap-Up) Potential Problems in MEDWatch, James G. Dickinson (MDDI, Apr 1994, p. 30). Keywords: Medical Device Reporting.
  • (Washington Wrap-Up) CDRH Analyzes Device Recalls, James G. Dickinson (MDDI, Apr 1994, p. 28). Keyword: Recalls.
  • (Washington Wrap-Up) FDA Rules Too Costly for Puritan-Bennett, James G. Dickinson (MDDI, Apr 1994, p. 26). Keywords: FDA Enforcement.
  • (Washington Wrap-Up) Overzealous Sales Pitch Retracted, James G. Dickinson (MDDI, Mar 1994, p. 45). Keyword: Marketing.
  • (Washington Wrap-Up) HIMA Opposes Hemodialyzer Reuse Guidance, James G. Dickinson (MDDI, Mar 1994, p. 45). Keyword: Reuse.
  • (Washington Wrap-Up) When FDA Refuses to Accept, James G. Dickinson (MDDI, Mar 1994, p. 44). Keyword: 510(k)s.
  • (Washington Wrap-Up) Discretionary Flexibility, James G. Dickinson (MDDI, Mar 1994, p. 44). Keyword: Guidelines.
  • (Washington Wrap-Up) Fear of FDA: How Justified?, James G. Dickinson (MDDI, Mar 1994, p. 42). Keywords: Industry Opinion.
  • (Guest Editorial) Optimum Science for Product Review--An Industry Perspective, James S. Benson (MDDI, Mar 1994, p. 28). Keywords: Product Approval.
  • Industry, FDA, and the Voice of Reason, John Bethune (MDDI, Mar 1994, p. 8). Keyword: GMPs.
  • (Washington Wrap-Up) FDA Faces Possible Lawsuit on Promotion Curbs, James G. Dickinson (MDDI, Feb 1994, p. 38). Keyword: Advertising.
  • (Washington Wrap-Up) FDA Willing to Discuss Dialyzer Reuse, James G. Dickinson (MDDI, Feb 1994, p. 37). Keyword: Reuse.
  • (Washington Wrap-Up) FDA Clarifies Rules for Foreign Data Sharing, James G. Dickinson (MDDI, Feb 1994, p. 37). Keywords: Freedom of Information.
  • Medical Device Labeling: A Comprehensive Approach, Kenneth Ross (MDDI, Jan 1994, p. 106). Keyword: Labeling.
  • (Washington Wrap-Up) Medtronic Endorses User Fees, James G. Dickinson (MDDI, Jan 1994, p. 61). Keywords: User Fees.
  • (Washington Wrap-Up) Heparin Analyzer Reclassified, James G. Dickinson (MDDI, Jan 1994, p. 60). Keyword: Reclassification.
  • (Washington Wrap-Up) Should Device Inventors Design Clinical Trials?, James G. Dickinson (MDDI, Jan 1994, p. 58). Keywords: Clinical Investigations.
  • (Washington Wrap-Up) Clinton's Green Light to New Regulations, James G. Dickinson (MDDI, Jan 1994, p. 56). Keywords: Regulatory Climate.
  • (Washington Wrap-Up) Clinton Loosens Reins on Secrets, James G. Dickinson (MDDI, Jan 1994, p. 54). Keywords: Freedom of Information.
  • (Washington Wrap-Up) FDA Seeks Quick, 'Temporary' PMA Suspensions, James G. Dickinson (MDDI, Jan 1994, p. 52). Keyword: PMA.
  • (Washington Wrap-Up) Executives in Handcuffs, James G. Dickinson (MDDI, Jan 1994, p. 48). Keyword: Enforcement.
  • (News) Proposed Revisions to GMP Released (MDDI, Jan 1994, p. 16). Keyword: GMPs.
Return to the top of the page

1993

  • Washington Wrap-Up: HIMA Accepts User Fees, but...; Log On to FDA Guidance; Alpert Impresses; FDA's First Civil Money Penalties; Tighter Hearing Aid Rules, James G. Dickinson (MDDI, Dec 1993, p. 20). Keywords: User Fees.
  • Medical Device Exports: Navigating FDA's Regulations, Jonathan S. Kahan (MDDI, Nov 1993, p. 82). Keywords: Regulations, Exports.
  • Washington Wrap-Up: Faster Device Approvals?; Menace of Civil Penalties; Aneurysm Clip Alert; Paper on a Stick=Device; Final Tracking Rule, James G. Dickinson (MDDI, Nov 1993, p. 34). Keywords: Diagnostics, FDAEnforcement, Product Approvals, Device Tracking, Safety Alert.
  • News: Electronic Signature Reg Nears Completion (MDDI, Nov 1993, p. 12). Keywords: Electronic Signatures.
  • Last Word on User Fees (The), John Bethune (MDDI, Nov 1993, p. 8). Keywords: User Fees, HIMA.
  • Keys to Calibration, Wallis Weiler Cady (MDDI, Oct 1993, p. 122). Keyword: GMPs.
  • How to Manage Regulatory Submissions for Device Modifications, Robert Sheridan (MDDI, Oct 1993, p. 64). Keyword: 510(k)s.
  • Washington Wrap-Up: FDA Monetary Penalties: How Fair?; Enforcement is Job One at FDA; FDA Teleconferes with Industry; J&J Research Deficiencies at Scripps Cited; Down-Classify Cardiopulmonary Bypass Pumps?, James G. Dickinson (MDDI, Oct 1993, p. 44). Keywords: FDAEnforcement, Classification, Government-Industry Relations, SMDA, Warning Letter.
  • News: Device Center Study Cites Common GMP Problems (MDDI, Oct 1993, p. 10). Keywords: CDRH, GMPs.
  • Health-Care Reform Reality (The), John Bethune (MDDI, Oct 1993, p. 8). Keywords: Health-Care Reform.
  • Simple Checklist for Validation Reports (A), Gale E. Van Buskirk (MDDI, Sep 1993, p. 122). Keyword: GMPs.
  • Speeding the Snail's Pace: FDA's New Review Policies, Howard M. Holstein (MDDI, Sep 1993, p. 52). Keywords: Product Approval.
  • FDA Notes: Implementing FDA's New Device Tracking Regulation, Donald E. Segal (MDDI, Sep 1993, p. 44). Keywords: Device Tracking.
  • Washington Wrap-Up: Reluctant OK for User Fees (A); Committee Report Supports Burlington; Recommendations for Reform; 510(k) Status Reporting System; FDA Moves against Sterilants; Changes at CDRH, James G. Dickinson (MDDI, Sep 1993, p. 38). Keywords: CDRH, FDAEnforcement, 510(k), User Fees, Government Criticism, Personnel.
  • News: HIMA Offers Device Tracking Guidance (MDDI, Sep 1993, p. 12). Keywords: Device Tracking.
  • Washington Wrap-Up: Sensible Approach to 510(k) Notifications (A); No New Evidence; 'Migrating Particles' Worry FDA Again, James G. Dickinson (MDDI, Aug 1993, p. 34). Keyword: FDAEnforcement.
  • Using Process Control Charts to Improve GMP Compliance, Ken Imler (MDDI, Jul 1993, p. 114). Keyword: GMPs.
  • Washington Wrap-Up: Drug-Model Warning Letters Hit Device Advertising; Female Condom Publicity Rebutted, James G. Dickinson (MDDI, Jul 1993, p. 38). Keywords: Advertising, Warning Letter.
  • News: Industry Members Support User Fees for Product Reviews (MDDI, Jul 1993, p. 10). Keywords: User Fees.
  • Evaluating GMP Training Consultants, Lisa Peterson (MDDI, Jun 1993, p. 128). Keyword: GMPs.
  • How CLIA May Affect the Agency and the Industry: An Interview with Thomas Tsakeris, Thomas Tsakeris (MDDI, Jun 1993, p. 60). Keywords: FDAEnforcement, CLIA88.
  • CLIA's Impact: Trouble Brewing for IVD Clearances?, Julie Zawisza (MDDI, Jun 1993, p. 55). Keyword: CLIA88.
  • Commercialization of Unapproved IVDs: Manufacturer Response to Emerging FDA Policy, Patricia Shrader (MDDI, Jun 1993, p. 52). Keyword: Commercialization.
  • Washington Wrap-Up: HIMA Rethinks User Fees for Device Applications; Andersen and Tsakeris Resign; What Constitutes Substantial Equivalence?, James G. Dickinson (MDDI, Jun 1993, p. 34). Keywords: User Fees, Regulations, FDAStaffing.
  • Face to Face: New Directions for FDA's Device Center?: An Interview with Bruce Burlington, MD, director, CDRH, Bruce Burlington (MDDI, Jun 1993, p. 26). Keyword: CDRH.
  • News: FDA's Ombudsman Passed Over in Center Turf Wars (MDDI, Jun 1993, p. 12). Keywords: Combination Devices.
  • News: Device Law Pioneer Dies, Larry R. Pilot (MDDI, Jun 1993, p. 10).
  • News: Son of Temple: CDRH Plans Follow-up Study (MDDI, Jun 1993, p. 10). Keywords: Clinical Studies.
  • Are User Fees Inevitable?, John Bethune (MDDI, Jun 1993, p. 8). Keywords: User Fees.
  • Determining Substantial Equivalence: New Challenges in the 510(k) Process, Jonathan S. Kahan (MDDI, May 1993, p. 82). Keyword: 510(k)s.
  • RBRVS--The Latest Battlefield in the Medical Technology-Reimbursement War, Gordon B. Schatz (MDDI, May 1993, p. 76). Keyword: Reimbursement.
  • FDA's Expanding Definition of Diagnostic Devices, Bradley Merrill Thompson (MDDI, May 1993, p. 58). Keywords: In Vitro Diagnostics.
  • Washington Wrap-Up: Kessler Meets HIMA: A Thaw?; Allen Out, Raab In at HIMA; HIMA Challenges FDA on Promotion; FDA on Cellular Phones, James G. Dickinson (MDDI, May 1993, p. 54). Keywords: Industry Relations, Government, Risk Assessment, HIMA.
  • Face to Face: Improved Science on Limited Resources: Breaking the Gridlock at ODE: An Interview with James Benson, Senior Vice President for Technology & Regulatory Affairs, HIMA, Washington, DC, James Benson (MDDI, May 1993, p. 42). Keywords: Material Toxicity, Product Approval.
  • News: CDRH and HIMA at Odds over Temple Report Findings (MDDI, May 1993, p. 20). Keywords: CDRH, Clinical Investigations.
  • Slow Road: FDA Progress on Implementing SMDA (A), Howard M. Holstein (MDDI, Apr 1993, p. 57). Keyword: SMDA.
  • Washington Wrap-Up: Kessler Retained; FDA to the Rescue; FDA Can Be Dangerous, Too; Temple Committee Findings; Erroneous Report on Breast Implants; FDA Unbound; Straight Talk from FDA, James G. Dickinson (MDDI, Apr 1993, p. 44). Keywords: Guidelines, FDAEnforcement, Government Criticism, Criticism Task Forces, Product Liability, Industry Opinion, Personnel, HIMA.
  • Guest Editorial: Industry Should Support User Fees, Robert Sheridan (MDDI, Apr 1993, p. 32). Keywords: User Fees.
  • News: Upgraded Labeling Proposed for Latex Products (MDDI, Apr 1993, p. 16). Keywords: Labeling, Materials Toxicity.
  • New Standards for Clinical Studies, John Bethune (MDDI, Apr 1993, p. 8). Keywords: Criticism Task Forces, Clinical Investigations.
  • Simple Checklist for Validation Protocols (A), Gale E. Van Buskirk (MDDI, Mar 1993, p. 110). Keyword: GMPs.
  • Washington Wrap-Up: Congressional Involvement: Less or More; More Like Drugs, James G. Dickinson (MDDI, Mar 1993, p. 24). Keywords: Government Intervention, Regulatory Climate.
  • News: Paperless FDA? (A) (MDDI, Mar 1993, p. 15). Keyword: Software.
  • Washington Wrap-Up: In Benson's Wake; Dingell Oversight; New Indications Bring Warning, James G. Dickinson (MDDI, Feb 1993, p. 30). Keywords: FDAEnforcement, FDAEnformcement.
  • News: The Next European Agenda: Action on the Environment (MDDI, Feb 1993, p. 15). Keywords: Environmental Impact.
  • News: FDA Drafts a Standards Policy (MDDI, Feb 1993, p. 10). Keyword: Standards.
  • Medical Device Reclassification: An Opportunity Ignored, Jonathan S. Kahan (MDDI, Jan 1993, p. 70). Keyword: Reclassification.
  • FDA Notes: Promoting Change at CDRH, William D. Appler (MDDI, Jan 1993, p. 58). Keywords: Government-Industry Cooperation.
  • Washington Wrap-Up: Good for Lawyers; Kessler and Benson Resign; Review Efficiencies in NIH Link; A Mandatory Recall, James G. Dickinson (MDDI, Jan 1993, p. 50). Keywords: Kessler, Political Influence, FDA, Benson, Recalls, Government-Industry Cooperation.
  • Guest Editorial: Do Preapproval Inspections Slow Product Reviews, Ronald M. Johnson (MDDI, Jan 1993, p. 34). Keywords: Premarket Approvals.
  • News: Low Profile for the EMC Directive (MDDI, Jan 1993, p. 14). Keywords: Electronic Devices, EEC.
  • Class Act (A), John Bethune (MDDI, Jan 1993, p. 10). Keyword: Classification.
Return to the top of the page

1992

  • Washington Wrap-Up: A Conversation with FDA's Alan Andersen, James G. Dickinson (MDDI, Dec 1992, p. 22). Keyword: FDAPolicy.
  • News: Pedersen details intercenter work processes (MDDI, Dec 1992, p. 10). Keyword: Organization.
  • News: Bush Signs User-Fee Bill--Devices Next? (MDDI, Dec 1992, p. 10). Keywords: User Fees.
  • Third-Party Solution (The)?, John Bethune (MDDI, Dec 1992, p. 8). Keyword: FDAPolicy.
  • Developing and Maintaining the Device Master Record, Jim Sandberg (MDDI, Nov 1992, p. 62). Keywords: Documentation, Device Master Files.
  • Washington Wrap-Up: Fixing What's Broke at FDA; CDRH Reorganization; User-Fee Legislation; Improving Submissions, James G. Dickinson (MDDI, Nov 1992, p. 32). Keywords: Policy, Product Approvals, CDRH, User Fees.
  • News: Implant Tracking, Retrieval, and Analysis: A Worthy Investment, MD&DI (MDDI, Nov 1992, p. 22). Keywords: Device Tracking.
  • News: Can Communication Overcome FDA Politics?, MD&DI (MDDI, Nov 1992, p. 10). Keywords: Policy, FDAEnforcement.
  • Washington Wrap-Up: Making Devices More Like Drugs; Untold stories of MDR abuse, James G. Dickinson (MDDI, Oct 1992, p. 30). Keywords: HRG, FDAEnforcement, Budget Cuts, MDR, Wolfe, Regulatory Climate, HIMA.
  • News: HIMA Launches Joint Meetings with FDA, MD&DI (MDDI, Oct 1992, p. 20). Keywords: HIMA, Government-Industry Cooperation.
  • FDA's New, Improved Approach to Device Tracking, Bradley Merrill Thompson (MDDI, Sep 1992, p. 34). Keywords: FDAEnforcement, Device Tracking.
  • Washington Wrap-Up: Congressional Corrections for Devices; EC, FDA enforcement helps exporters; Patient restraint guidelines; Five more Class III preamendment rules, James G. Dickinson (MDDI, Sep 1992, p. 24). Keywords: FDA Enforcement, Legislation, Classification, Safety, International Affairs, Amendments, SMDA, PMA.
  • Uncertain Future for Product Clearances, Jonathan S. Kahan (MDDI, Sep 1992, p. 20). Keywords: FDAEnforcemnt, Product Approval.
  • News: Rethinking Tissue Regulation, MD&DI (MDDI, Sep 1992, p. 10). Keywords: GMPs, Transparent Tissue.
  • CLIA '88 regulation's effect on labeling (The), Gordon B. Schatz (MDDI, Aug 1992, p. 34). Keywords: CLIA '88.
  • Washington Wrap-Up: Curbing device marketers; CDRH tension eases; FDA wants more power, James G. Dickinson (MDDI, Aug 1992, p. 28). Keywords: CDRH, FDA Policy.
  • Washington Wrap-Up: Naming names at FDA; Device-science task force; Common sense, Anyone?, James G. Dickinson (MDDI, Jul 1992, p. 36). Keywords: Criticism Task Forces, Labeling, Personnel.
  • Reexamining FDA's RAISE program, Kshitij Mohan (MDDI, Jul 1992, p. 32). Keywords: FDA Enforcement, Signigicant Risk, Standards, Risk Assessment.
  • News: U.S. industry conceding leadership to other nations, report charges, MD&DI (MDDI, Jul 1992, p. 10). Keyword: Standards.
  • News: Device tracking derails (MDDI, Jul 1992, p. 10). Keywords: Device Tracking.
  • Computerized medical device tracking: a survey, Dick Landis (MDDI, Jun 1992, p. 103). Keywords: Regulatory Affairs, Device Tracking, Postmarket Surveillance.
  • Effects of CLIA '88 on IVD design and marketing, Kicab Castaneda-Mendez (MDDI, Jun 1992, p. 99). Keywords: CLIA88, Manufacturing, QA/QC, Laboratories.
  • How the environmental movement is 'greening' the medical device industry, Wayne Rogers (MDDI, Jun 1992, p. 96). Keywords: Environmental Impact, Regulatory Affairs.
  • Combination products: FDA's new regulation and intercenter agreements, Jonathan S. Kahan (MDDI, Jun 1992, p. 84). Keywords: Combination Products.
  • Educated 'no' (An), William D. Appler (MDDI, Jun 1992, p. 52). Keywords: Regulatory Affairs, Government-Industry Cooperation.
  • Washington Wrap-up: Revolution at FDA; Device tracking, James G. Dickinson (MDDI, Jun 1992, p. 42). Keywords: Congressional Hearings, CDRH, Device Tracking, Management.
  • Face to face with FDA: an interview with David A. Kessler, MD, Commissioner, FDA, James G. Dickinson (MDDI, Jun 1992, p. 36). Keywords: FDAEnforcement, Risk Assessment.
  • News: OSHA blood regulations will affect manufacturers (MDDI, Jun 1992, p. 23). Keywords: AIDS, Occupational Safety.
  • News: FDA and devices as political footballs (MDDI, Jun 1992, p. 20). Keywords: Political Influence, Regulatory Climate.
  • News: Slower product approvals confirmed (MDDI, Jun 1992, p. 12). Keywords: Product Approval.
  • Washington Wrap-up: FDA-HIMA cooperation; Secret service agent at FDA; Siemens cited for minimizing complaints; Device-CME policy, James G. Dickinson (MDDI, May 1992, p. 28). Keywords: Safe Medical Devices Act, Complaints, Warning Letter, Personnel, Postmarket Surveillance, Government-Industry Cooperation.
  • Pitfalls of linking GMP inspections to product clearances (The), Jonathan S. Kahan (MDDI, May 1992, p. 20). Keywords: Premarket Approvals, GMPs, Inspections.
  • News: HIMA task force urges change in FDA enforcement policies (MDDI, May 1992, p. 10). Keywords: FDAEnforcement, Industry Opinion, Inspections.
  • Relationship in crisis (A), John Bethune (MDDI, May 1992, p. 8). Keywords: Competitiveness, Government-Industry Cooperation.
  • Sorting through the European rules for electromagnetic compatibility, Gene A. Panger (MDDI, Apr 1992, p. 90). Keywords: Electromagnetic Compatibility, Electronic Devices, European Regulations.
  • After the inspection: minimizing the effects of a Form FDA 483 or an inaccurate EIR, Larry R. Pilot (MDDI, Apr 1992, p. 75). Keywords: Regulatory Affairs, Inspections.
  • Washington Wrap-up: FDA headed for a fall?; FDA's field out of control?;, James G. Dickinson (MDDI, Apr 1992, p. 28). Keywords: FDAEnforcement, District Offices, Regulatory Climate, Industry Opinion.
  • Face to face with FDA: an interview with Philip B. White, Director, Office of Standards and Regulations, CDRH, Cliff Henke (MDDI, Apr 1992, p. 22). Keywords: Harmonization, Standards, International Affairs.
  • Lengthy patent terms stifle innovation, Ronald E. Lund (MDDI, Apr 1992, p. 18). Keywords: Patent Term Extension, Innovation, Patents.
  • News: Toxicity data base urged (MDDI, Apr 1992, p. 16). Keywords: Biomaterials, Toxicity, Materials Toxicity.
  • News: Recycling possible only by manufacturer involvement, says consultant (MDDI, Apr 1992, p. 15). Keywords: Recycling, Packaging.
  • News: RAISE escalates industry backlash (MDDI, Apr 1992, p. 10). Keywords: Regulatory Climate, Industry Opinion, Critical Devices.
  • IRB Q&A, Samuel Herman (MDDI, Mar 1992, p. 74). Keywords: IRBs, Reimbursement, Informed Consent, Clinical Investigations.
  • User facility, distributor, and manufacturer medical device reporting: FDA's proposed new rules, Howard M. Holstein (MDDI, Mar 1992, p. 58). Keywords: User Reporting, Problem Reporting, MDR.
  • Washington Wrap-up: When compliance is voluntary; Preapproval inspections for 510(k)s; User reporting rule; International Harmonization, James G. Dickinson (MDDI, Mar 1992, p. 40). Keywords: User Reporting, FDAEnforcement, Harmonization, Compliance, 510(k)s, Management, Inspections.
  • Face to face with FDA: an interview with James S. Benson, Director, CDRH, Cliff Henke (MDDI, Mar 1992, p. 30). Keywords: Management, Regulatory Climate.
  • News: Market opportunities in health-care reform (MDDI, Mar 1992, p. 12). Keywords: Health-Care Reform, Cost Containment, Health Insurance.
  • Zero-risk society (The), John Bethune (MDDI, Mar 1992, p. 8). Keywords: Public Opinion.
  • Washington Wrap-up: 'Transitional device' data; First mandatory suspension; Draft guidance surveillance; Drugs of abuse screen; Combination products guidelines, James G. Dickinson (MDDI, Feb 1992, p. 26). Keywords: Diagnostics, Guidelines, FDAEnforcement, Reclassification, Surgical Devices, Combination Products, Hometesting, Postmarket Surveillance.
  • Face to face with FDA: an interview with David West, Deputy Director, Office of Device Evaluation, CDRH, Cliff Henke (MDDI, Feb 1992, p. 18). Keywords: ODE, Regulatory Climate, Product Approval.
  • News: Proposed GMP changes could undermine quality, industry official says (MDDI, Feb 1992, p. 10). Keywords: Audits, Inspections, GMPs.
  • News: Industry wary of user reporting rule (MDDI, Feb 1992, p. 10). Keywords: User Reporting.
  • Information overload?, John Bethune (MDDI, Feb 1992, p. 8). Keywords: Editorial Opinion, User Reporting.
  • IRB Q&A, Samuel Herman (MDDI, Jan 1992, p. 142). Keywords: IRBs, Clinical Investigations, Informed Consent.
  • What FDA can--and cannot--do during an inspection, Larry R. Pilot (MDDI, Jan 1992, p. 69). Keywords: Regulatory Affairs, Inspections.
  • Investigational and research use of in vitro diagnostics: FDA's new guidance, Jonathan S. Kahan (MDDI, Jan 1992, p. 66). Keywords: Diagnostics, Regulation.
  • New regulatory framework takes shape (The), Trevor McPherson (MDDI, Jan 1992, p. 54). Keywords: Regulations, Exports, Australia.
  • ISO 9001 and the upcoming revised GMP regulation, H. Neal Dunning (MDDI, Jan 1992, p. 40). Keywords: Harmonization, GMPs.
  • Washington Wrap-up: Early spring? (An); Publicity as Punishment; Device Sterilization, James G. Dickinson (MDDI, Jan 1992, p. 34). Keywords: Sterilization, FDAEnforcement, Standards, Regulatory Climate, Warning Letter.
  • FDA's enforcement renaissance and medical devices, Ronald M. Johnson (MDDI, Jan 1992, p. 28). Keywords: FDAEnforcement, Compliance, Regulatory Climate.
  • News: More detailed roadmap to the CE mark (A) (MDDI, Jan 1992, p. 12). Keywords: EC92, European Regulations.
  • News: New twist in clinical utility debate (MDDI, Jan 1992, p. 12). Keywords: Ob/Gyn Devices, Clinical Utility.
Return to the top of the page

1991

  • Sampling strategies for personal monitoring, Jeremy Bachmann (MDDI, Dec 1991, p. 37). Keywords: Et OExposure, Occupational Safety.
  • Checklist accelerates the review of PMA applications, Mary R. Hanna (MDDI, Dec 1991, p. 28). Keywords: Premarket Approvals.
  • Washington Wrap-up: FDA draws more fire, James G. Dickinson (MDDI, Dec 1991, p. 25). Keywords: Political Influence, Regulatory Climate, Industry Opinion.
  • Washington Wrap-up: Seizures up 30%, James G. Dickinson (MDDI, Dec 1991, p. 24). Keyword: FDAEnforcement.
  • Washington Wrap-up: Industry resistance surfaces, James G. Dickinson (MDDI, Dec 1991, p. 22). Keywords: FDAEnforcement, Regulatory Climate, Industry Opinion.
  • New way of thinking about FDA (A), John Brown (MDDI, Dec 1991, p. 14). Keywords: Forecasts, Regulatory Climate.
  • Index to the future? (An), John Bethune (MDDI, Dec 1991, p. 8). Keyword: Forecasts.
  • Washington Wrap-up: Too much specificity, James G. Dickinson (MDDI, Nov 1991, p. 27). Keyword: FOI.
  • Washington Wrap-up: Two views of clinical utility, James G. Dickinson (MDDI, Nov 1991, p. 27). Keywords: Clinical Utility.
  • Washington Wrap-up: What you must never do, James G. Dickinson (MDDI, Nov 1991, p. 26). Keywords: Political Influence, Product Approval.
  • Washington Wrap-up: Publicity as enforcement tool, James G. Dickinson (MDDI, Nov 1991, p. 24). Keyword: FDAEnforcement.
  • FDA: moving aggressively toward the future, Louis W. Sullivan (MDDI, Nov 1991, p. 12). Keywords: FDAEnforcement, Management, Product Approval.
  • Clinical utility and medical device premarket approval, Jonathan S. Kahan (MDDI, Oct 1991, p. 62). Keywords: Premarket Approvals, Clinical Utility.
  • Biological in vitro diagnostics, Amiram Daniel (MDDI, Oct 1991, p. 34). Keywords: Diagnostics, Blood Devices, CBER.
  • FDA looks at infusion pumps, C. Kaye Riley (MDDI, Oct 1991, p. 32). Keywords: Infusion Pumps.
  • Washington Wrap-up: FDA getting through, James G. Dickinson (MDDI, Oct 1991, p. 28). Keywords: Management, Product Approval, Government-Industry Cooperation.
  • Quality and cooperation, John Bethune (MDDI, Oct 1991, p. 8). Keyword: Quality.
  • Washington Wrap-up: 'Nauseous rhetoric' of enforcement, James G. Dickinson (MDDI, Sep 1991, p. 97). Keywords: FDAEnforcement, Regulatory Climate.
  • IRB Q&A, Samuel Herman (MDDI, Sep 1991, p. 76). Keywords: IRBs, Informed Consent, Clinical Investigations.
  • Handling complaints systematically: the right approach, Barry V. Ashar (MDDI, Sep 1991, p. 53). Keywords: Complaints, Product Complaints.
  • SMDA: certify and summarize, H. Neal Dunning (MDDI, Sep 1991, p. 30). Keywords: Safe Medical Devices Act, 510(k)s.
  • Washington Wrap-up: First warning letters issued, James G. Dickinson (MDDI, Sep 1991, p. 24). Keywords: FDAEnforcement, Warning Letter.
  • Fences or ambulances: choosing preventive solutions for patient and provider safety, Norman F. Estrin (MDDI, Sep 1991, p. 10). Keyword: Safety.
  • SafeMed: Provide or promise, H. Neal Dunning (MDDI, Aug 1991, p. 30). Keywords: Safe Medical Devices Act, Compliance, 510(k)s.
  • Washington Wrap-up: Contract manufacturing, James G. Dickinson (MDDI, Aug 1991, p. 26). Keywords: Terminology, Contract Manufacturing.
  • Washington Wrap-up: New FDA policies, James G. Dickinson (MDDI, Aug 1991, p. 24). Keywords: Policy, CDRH, Product Approval.
  • Washington Wrap-up: Finding a balance, James G. Dickinson (MDDI, Aug 1991, p. 24). Keywords: Regulatory Climate, Industry Opinion.
  • Washington Wrap-up: Enforcement methods expand, James G. Dickinson (MDDI, Aug 1991, p. 22). Keyword: FDAEnforcement.
  • Washington Wrap-up: Goodby, regulatory letter, James G. Dickinson (MDDI, Jul 1991, p. 22). Keywords: FDAEnforcement, Regulatory Letter, Warning Letter.
  • Washington Wrap-up: Shiley, Inc.: a case in point?, James G. Dickinson (MDDI, Jul 1991, p. 22). Keyword: FDAEnforcement.
  • Washington Wrap-up: More FDA saber rattling, James G. Dickinson (MDDI, Jul 1991, p. 20). Keyword: FDAEnforcement.
  • Enforcement horror stories catch CEOs unprepared, Cheryl Doriot (MDDI, Jul 1991, p. 8). Keywords: Regulatory Climate.
  • IRB Q&A, Samuel Herman (MDDI, Jun 1991, p. 170). Keywords: IRBs, Commercialization, Informed Consent.
  • FDA restrictions on the commercialization of investigational devices, Jonathan S. Kahan (MDDI, Jun 1991, p. 80). Keywords: Commercialization, IDEs.
  • Dealing with FDA when enforcement activities intensify, William D. Appler (MDDI, Jun 1991, p. 34). Keyword: FDAEnforcement.
  • Washington Wrap-up: Device labeling, James G. Dickinson (MDDI, Jun 1991, p. 32). Keywords: Terminology, Labeling.
  • Washington Wrap-up: Kessler gets tough, James G. Dickinson (MDDI, Jun 1991, p. 30). Keywords: FDAEnforcement, Management.
  • Industry at a crossroads (An), David M. Link (MDDI, Jun 1991, p. 16). Keywords: Regulatory Affairs, Regulatory Climate, Industry Opinion.
  • Cost of noncompliance goes up (The), Cheryl Doriot (MDDI, Jun 1991, p. 8). Keywords: Regulatory Affairs, Regulatory Climate.
  • Washington Wrap-up: FDA criminal investigators, James G. Dickinson (MDDI, May 1991, p. 26). Keyword: FDAEnforcement.
  • Washington Wrap-up: Getting priority review, James G. Dickinson (MDDI, May 1991, p. 22). Keywords: Breakthrough Devices, Product Approval.
  • CE mark (The): a Pandora's box, Cheryl Doriot (MDDI, May 1991, p. 8). Keywords: European Regulations, Product Approval.
  • Putting the squeeze on Medicare reimbursement, Robert F. Leibenluft (MDDI, Apr 1991, p. 43). Keywords: Reimbursement, Outpatient Treatments.
  • Implant tracking, surveillance, and retrieval, Elaine Duncan (MDDI, Apr 1991, p. 30). Keywords: Implants, Safe Medical Devices Act.
  • Washington Wrap-up: Clarifying a 'clarification', James G. Dickinson (MDDI, Apr 1991, p. 22). Keywords: Surgical Devices, Labeling.
  • Law that challenges our resilience (A), Kshitij Mohan (MDDI, Apr 1991, p. 14). Keywords: Safe Medical Devices Act, Industry Opinion.
  • ISO 9001 and looking to the future, Cheryl Doriot (MDDI, Apr 1991, p. 8). Keyword: GMPs.
  • IRB Q&A, Samuel Herman (MDDI, Mar 1991, p. 96). Keywords: IRBs, Informed Consent, Clinical Investigations.
  • Good guys, bad guys, and device reviews, William D. Appler (MDDI, Mar 1991, p. 32). Keywords: Policy, FDAEnforcement.
  • Medicare coverage for technology: new dimensions from the courts and Congress, Gordon B. Schatz (MDDI, Mar 1991, p. 26). Keyword: Reimbursement.
  • Washington Wrap-up: Paperwork reduction, James G. Dickinson (MDDI, Mar 1991, p. 22). Keyword: Exports.
  • Washington Wrap-up: FDA praises Shiley, James G. Dickinson (MDDI, Mar 1991, p. 22). Keywords: Safety Alert.
  • Washington Wrap-up: Debarment bill unnecessary?, James G. Dickinson (MDDI, Mar 1991, p. 21). Keywords: FDAEnforcement, Legislation.
  • Washington Wrap-up: More enforcement (again), James G. Dickinson (MDDI, Mar 1991, p. 20). Keywords: Kessler, Regulatory Climate.
  • Using outcomes to redefine cost containment, Ben L. Holmes (MDDI, Mar 1991, p. 12). Keywords: Cost Containment, Outcomes.
  • Washington Wrap-up: Goodbye, presubmission review, James G. Dickinson (MDDI, Feb 1991, p. 68). Keyword: FOI.
  • Implications of the Safe Medical Devices Act of 1990 (The), Jonathan S. Kahan (MDDI, Feb 1991, p. 44). Keywords: FDAEnforcement, Safe Medical Devices Act, Regulatory Affairs.
  • Washington Wrap-up: Electromedical classification, James G. Dickinson (MDDI, Feb 1991, p. 29). Keywords: Electronic Devices, Classification.
  • Washington Wrap-up: Independent sampling of 510(k)s, James G. Dickinson (MDDI, Feb 1991, p. 29). Keyword: 510(k)s.
  • Washington Wrap-up: How industry got shut out, James G. Dickinson (MDDI, Feb 1991, p. 24). Keywords: Safe Medical Devices Act, Political Influence, Regulatory Climate.
  • IRB Q&A, Samuel Herman (MDDI, Jan 1991, p. 144). Keywords: IRBs, Informed Consent, Clinical Investigations.
  • Safe Medical Devices Act of 1990 (The), Jonathan S. Kahan (MDDI, Jan 1991, p. 66). Keywords: Safe Medical Devices Act.
  • Getting the most from your patents, Barbara J. Luther (MDDI, Jan 1991, p. 46). Keywords: Patent Term Extension, Patents.
  • Who bears the responsibility when device companies violate the law?, William D. Appler (MDDI, Jan 1991, p. 38). Keyword: FDAEnforcement.
  • Washington Wrap-up: For the record, James G. Dickinson (MDDI, Jan 1991, p. 34). Keyword: FDAEnforcement.
  • Washington Wrap-up: Expanding 'regulatory stream' (The), James G. Dickinson (MDDI, Jan 1991, p. 32). Keywords: Technology Assessment, Product Approval.
  • Washington Wrap-up: Device law overhaul, James G. Dickinson (MDDI, Jan 1991, p. 30). Keywords: Safe Medical Devices Act.
  • Safe Medical Devices Act of 1990 (The): looking back--but moving forward, Alan H. Magazine (MDDI, Jan 1991, p. 18). Keywords: Safe Medical Devices Act, Regulatory Climate, Industry Opinion.
  • Safe Medical Devices Act of 1990 (The): the challenge ahead, Larry R. Pilot (MDDI, Jan 1991, p. 14). Keywords: Safe Medical Devices Act, Regulatory Climate, Criticism.
  • FDA goals and the course ahead, Louis W. Sullivan (MDDI, Jan 1991, p. 10). Keywords: Forecasts, Public Health Promotion.
Return to the top of the page

1990

  • Washington Wrap-up: Class II for 'shock' devices, James G. Dickinson (MDDI, Dec 1990, p. 27). Keywords: Electroconvulsive Therapy.
  • Washington Wrap-up: New fraud policy, James G. Dickinson (MDDI, Dec 1990, p. 25). Keywords: Policy, FDAEnforcement.
  • Washington Wrap-up: Regulation confronts technology, James G. Dickinson (MDDI, Dec 1990, p. 22). Keywords: CLIA88, Industry Opinion, Laboratories.
  • Washington Wrap-up: Budget woes, James G. Dickinson (MDDI, Dec 1990, p. 22). Keywords: Cost Containment, Budget Cuts.
  • New law casts a somber mood, Cheryl Doriot (MDDI, Dec 1990, p. 8). Keywords: Safe Medical Devices Act, Forecasts.
  • Hybrid software development model for medical instruments (A), Steven R. Mallory (MDDI, Nov 1990, p. 41). Keywords: Software, Development.
  • More on filing supplements for changes in 510(k)'d devices, William D. Appler (MDDI, Nov 1990, p. 30). Keyword: 510(k)s.
  • Washington Wrap-up: Measuring therapy outcomes, James G. Dickinson (MDDI, Nov 1990, p. 29). Keyword: Outcomes.
  • Washington Wrap-up: No more Mr. Nice Guy, James G. Dickinson (MDDI, Nov 1990, p. 26). Keywords: Regulatory Climate.
  • Face to face with FDA: an interview with Robert L. Sheridan, Director, Office of Device Evaluation, CDRH (MDDI, Nov 1990, p. 18). Keywords: Advisory Panels, Product Approval.
  • Design controls make sense, Cheryl Doriot (MDDI, Nov 1990, p. 8). Keywords: Design Controls, GMPs.
  • GMP for IVDs (The): the second round, Amiram Daniel (MDDI, Oct 1990, p. 38). Keywords: Diagnostics, Regulation, GMPs.
  • ODE offers advice on submitting supplements to PMAs, 510(k)s, William D. Appler (MDDI, Oct 1990, p. 32). Keywords: Premarket Approvals.
  • Washington Wrap-up: Enforcement report, James G. Dickinson (MDDI, Oct 1990, p. 30). Keyword: FDAEnforcement.
  • Washington Wrap-up: HR 3095 analysis, James G. Dickinson (MDDI, Oct 1990, p. 29). Keywords: Safe Medical Devices Act, Legislation.
  • Washington Wrap-up: Market exclusivity debate, James G. Dickinson (MDDI, Oct 1990, p. 26). Keywords: Marketing, Legislation.
  • Face to face with FDA: an interview with Ann B. Holt, Acting Director, Office of Compliance and Surveillance, CDRH (MDDI, Oct 1990, p. 18). Keywords: FDAEnforcement, MDR, Compliance.
  • In defense of the 510(k) process, Ravi Chinta (MDDI, Oct 1990, p. 14). Keywords: 510(k)s, Product Approval.
  • Export and import of medical devices: navigating FDA's tougher regulatory waters, Jonathan S. Kahan (MDDI, Sep 1990, p. 54). Keywords: Regulations, Exports, Imports.
  • Washington Wrap-up: Why the slowdown?, James G. Dickinson (MDDI, Sep 1990, p. 33). Keywords: Product Approval.
  • Washington Wrap-up: Lawbreaking start-ups, James G. Dickinson (MDDI, Sep 1990, p. 30). Keywords: IDEs, Clinical Investigations.
  • Face to face with FDA: an interview with Joseph S. Arcarese, Director, Office of Training and Assistance, CDRH (MDDI, Sep 1990, p. 20). Keywords: Public Health Promotion, End-Users, Assistance.
  • Technology assessment and outcomes research: the twin peaks of tomorrow's health-care landscape, Edward C. Bessey (MDDI, Sep 1990, p. 10). Keywords: Technology Assessment, Outcomes.
  • Lifting the burden of IDE regulations off device feasibility studies, Bradley Merrill Thompson (MDDI, Aug 1990, p. 44). Keywords: IDEs, Research, Feasibility Studies.
  • Clearing the approval barrier in Australia, Trevor McPherson (MDDI, Aug 1990, p. 42). Keyword: Australia.
  • Washington Wrap-up: O'Connell honored, James G. Dickinson (MDDI, Aug 1990, p. 35). Keywords: Diagnostics, Personnel.
  • Washington Wrap-up: FDA debarments?, James G. Dickinson (MDDI, Aug 1990, p. 34). Keywords: FDAEnforcement, Legislation.
  • Face to face with FDA: an interview with W. Fred Hooten, Director, Division of Compliance Programs, Office of Compliance and Surveillance (MDDI, Aug 1990, p. 16). Keywords: Compliance, Government-Industry Cooperation, Inspections, GMPs.
  • Washington Wrap-up: Clinging to IVD 0.1% SAL, James G. Dickinson (MDDI, Jul 1990, p. 60). Keywords: Diagnostics, Regulation, Sterility Assurance.
  • Efficacy testing of antimicrobial agents, Gayle K. Mulberry (MDDI, Jul 1990, p. 50). Keywords: Antimicrobial Agents.
  • What device manufacturers need to know, William D. Appler (MDDI, Jul 1990, p. 32). Keywords: Regulatory Affairs, Forecasts, Regulatory Climate.
  • Washington Wrap-up: In-use monitoring by FDA, James G. Dickinson (MDDI, Jul 1990, p. 30). Keyword: Gloves.
  • News: Health outcomes to dominate device market (MDDI, Jul 1990, p. 23). Keywords: Cost Containment, Reimbursement, Outcomes.
  • News: Tougher drug rules may affect devices (MDDI, Jul 1990, p. 22). Keywords: Premarket Approvals, Regulatory Climate.
  • Face to face with FDA: an interview with Walter Gundaker, Acting Deputy Director, CDRH (MDDI, Jul 1990, p. 16). Keywords: FDAEnforcement, Legislation, MDR, Assistance.
  • No rest for the regulated, Cheryl Doriot (MDDI, Jul 1990, p. 8). Keyword: GMPs.
  • Medical device competitors: playing on a level field, Jeffrey N. Gibbs (MDDI, Jun 1990, p. 105). Keywords: Unfair Competition, Lanham Act, FDAEnforcement.
  • Clarifying FDA's policy on device modifications, Jonathan S. Kahan (MDDI, Jun 1990, p. 101). Keywords: Premarket Approvals, 510(k)s, IDEs.
  • International standards: harmonizing to a European tune, Gary M. Stephenson (MDDI, Jun 1990, p. 97). Keywords: Harmonization, International Affairs, European.
  • Australian rules, Trevor McPherson (MDDI, Jun 1990, p. 88). Keywords: International Affairs, Australia.
  • Device master files, Stan Stringer (MDDI, Jun 1990, p. 60). Keywords: Device Master Files.
  • International regulatory update, Amiram Daniel (MDDI, Jun 1990, p. 52). Keywords: Diagnostics, Regulation, International Affairs.
  • FDA and Maryland cooperate on devices, William D. Appler (MDDI, Jun 1990, p. 46). Keywords: International Affairs, Biotechnology.
  • Washington Wrap-up: New mailing addresses, James G. Dickinson (MDDI, Jun 1990, p. 44). Keywords: Premarket Approvals, MDR.
  • Washington Wrap-up: Flawed endoscope washer design?, James G. Dickinson (MDDI, Jun 1990, p. 42). Keywords: Advertising, Sterilization, Failure Analysis.
  • Washington Wrap-up: Unapproved, unreported, James G. Dickinson (MDDI, Jun 1990, p. 42). Keywords: Ob/Gyn Devices.
  • Washington Wrap-up: 'Controlling' devices, James G. Dickinson (MDDI, Jun 1990, p. 40). Keywords: Regulatory Climate.
  • News: Physician payment reform will affect manufacturers (MDDI, Jun 1990, p. 36). Keywords: Reimbursement, Physicians.
  • News: California proposes EtO controls (MDDI, Jun 1990, p. 34). Keywords: Et O, California, Et OResiduals.
  • News: Occupational radiation standards may toughen (MDDI, Jun 1990, p. 32). Keywords: Occupational Safety.
  • Face to face with FDA: an interview with Elizabeth D. Jacobson, Director, Office of Science and Technology, CDRH, FDA (MDDI, Jun 1990, p. 18). Keywords: Tests, Research, Product Approval.
  • EC directives don't spell harmony yet, Kshitij Mohan (MDDI, Jun 1990, p. 10). Keywords: Europe, European Regulations.
  • Preserving our spirit of cooperation, Cheryl Doriot (MDDI, Jun 1990, p. 8). Keywords: Cooperation, Government-Industry Cooperation.
  • Conformance in a nutshell: assessing adherence to voluntary standards, Eduardo March (MDDI, May 1990, p. 40). Keywords: Voluntary Standards, Classification.
  • Medicare's new RVS: manufacturers beware, Ted R. Mannen (MDDI, May 1990, p. 38). Keywords: Reimbursement, Medicare, Physicians.
  • FDA Notes: Clinical outcomes and device review, William D. Appler (MDDI, May 1990, p. 33). Keywords: Clinical Investigations, Product Approval.
  • FDA Notes: AIDS transmission by medical devices, William D. Appler (MDDI, May 1990, p. 32). Keyword: Reuse.
  • FDA Notes: ODE guidance, William D. Appler (MDDI, May 1990, p. 32). Keywords: ODE, Guidelines.
  • Washington Wrap-up: Jarvik update, James G. Dickinson (MDDI, May 1990, p. 29). Keywords: Cardiovascular Devices.
  • Washington Wrap-up: FDA device corruption?, James G. Dickinson (MDDI, May 1990, p. 27). Keywords: Government Criticism, 510(k)s.
  • Washington Wrap-up: Eleven GMP observations, James G. Dickinson (MDDI, May 1990, p. 27). Keywords: FDAEnforcement, GMPs.
  • Washington Wrap-up: Shiley showed MDR's importance, James G. Dickinson (MDDI, May 1990, p. 26). Keyword: MDR.
  • Washington Wrap-up: Datascope, a case in point, James G. Dickinson (MDDI, May 1990, p. 24). Keyword: FDAEnforcement.
  • Washington Wrap-up: Focus on enforcement, James G. Dickinson (MDDI, May 1990, p. 24). Keyword: FDAEnforcement.
  • New rules for a new decade, Trevor McPherson (MDDI, Apr 1990, p. 44). Keyword: Australia.
  • Proficiency testing, Amiram Daniel (MDDI, Apr 1990, p. 34). Keywords: Diagnostics, Proficiency Testing.
  • Enforcement review, 1989, William D. Appler (MDDI, Apr 1990, p. 30). Keyword: FDAEnforcement.
  • Washington Wrap-up: Withdrawal of Jarvik heart's IDE, James G. Dickinson (MDDI, Apr 1990, p. 27). Keywords: FDAEnforcement, Cardiovascular Devices.
  • Washington Wrap-up: FDA criminal powers come home, James G. Dickinson (MDDI, Apr 1990, p. 26). Keywords: FDAEnforcement, Trade Secrets, Government Relations.
  • Washington Wrap-up: 1980s witnessed a device boom (The), James G. Dickinson (MDDI, Apr 1990, p. 24). Keywords: Premarket Approvals, 510(k)s.
  • News: CFC surtax kicks in (MDDI, Apr 1990, p. 19). Keywords: Costs, CFCs.
  • News: Consortium to evaluate medical technology (MDDI, Apr 1990, p. 18). Keywords: Cost Containment, Technology Assessment.
  • News: FDA publishes R&D 'wish list' (MDDI, Apr 1990, p. 16). Keywords: R&D, Research.
  • Cost-effectiveness: new yardstick for medical device evaluation, Gary M. Stephenson (MDDI, Mar 1990, p. 71). Keywords: Cost Containment, Reimbursement, Outcomes.
  • FDA regulators in the land of cotton, Miles Weiss (MDDI, Mar 1990, p. 54). Keywords: Southeast, Regulatory Climate.
  • Market Report: Emerging medical-waste industry (The), Pieter Halter (MDDI, Mar 1990, p. 48). Keywords: Waste Management, Medical Waste.
  • Some free advice for ODE, William D. Appler (MDDI, Mar 1990, p. 36). Keywords: ODE, 510(k)s, Industry Opinion.
  • Washington Wrap-up: Pursuing 'clinical benefit', James G. Dickinson (MDDI, Mar 1990, p. 32). Keywords: Premarket Approvals.
  • News: Low-level radiation: unsafe at any dose (MDDI, Mar 1990, p. 18). Keywords: Standards, Radiology Devices.
  • News: US may ease high-tech controls (MDDI, Mar 1990, p. 18). Keywords: International Trade, Exports.
  • Message from the chairman, Jerry E. Robertson (MDDI, Mar 1990, p. 10). Keyword: HIMA.
  • IRB Q&A, Samuel Herman (MDDI, Feb 1990, p. 52). Keywords: IRBs, MDR, Clinical Investigations.
  • News from the IVD front: Home-use IVDs, Amiram Daniel (MDDI, Feb 1990, p. 34). Keywords: Diagnostics, Home Testing.
  • FDA appeals process (The), William D. Appler (MDDI, Feb 1990, p. 30). Keywords: Adverse Decisions, Appeals.
  • Washington Wrap-up: Glove adulteration, James G. Dickinson (MDDI, Feb 1990, p. 29). Keyword: Gloves.
  • Washington Wrap-up: Hip prostheses into Class II, James G. Dickinson (MDDI, Feb 1990, p. 29). Keywords: Implants, Reclassification.
  • Washington Wrap-up: 'Serious problems pervade devices', James G. Dickinson (MDDI, Feb 1990, p. 28). Keywords: Congressional Hearings, Government Criticism.
  • Washington Wrap-up: Benson 'rescued', James G. Dickinson (MDDI, Feb 1990, p. 27). Keywords: Political Influence, Management.
  • Washington Wrap-up: Safe custody of trade secrets, James G. Dickinson (MDDI, Feb 1990, p. 26). Keywords: Trade Secrets, FOI.
  • News: Ultrasound labeling standards coming: fetal Doppler guidelines here (MDDI, Feb 1990, p. 18). Keywords: Ultrasound, Labeling.
  • More news on IVDs, Cheryl Doriot (MDDI, Feb 1990, p. 8). Keyword: Diagnostics.
  • FDA's 510(k) review procedure for medical devices, Richard R. Scott (MDDI, Jan 1990, p. 62). Keywords: 510(k)s, Product Approval.
  • Medical device reporting: compliance and controversy, Jonathan S. Kahan (MDDI, Jan 1990, p. 58). Keywords: Compliance, MDR.
  • Perspectives on the 1990s, Greg Freiherr (MDDI, Jan 1990, p. 52). Keywords: Cost Containment, Forecasts, Regulatory Climate.
  • Outcomes research: a new revolution waiting in the wings?, George M. Naimark (MDDI, Jan 1990, p. 42). Keywords: Legislation, R&D, Outcomes.
  • Radical change in European medical device standards, Mika O. Reinikainen (MDDI, Jan 1990, p. 38). Keywords: Standards, European Regulations.
  • Some thoughts on device recalls, William D. Appler (MDDI, Jan 1990, p. 26). Keyword: Recalls.
  • Washington Wrap-up: Hip prosthesis technology, James G. Dickinson (MDDI, Jan 1990, p. 25). Keyword: Implants.
  • Washington Wrap-up: Preproduction QA guidelines, James G. Dickinson (MDDI, Jan 1990, p. 24). Keywords: Preproduction QA, Guidelines, Software.
  • Washington Wrap-up: Huge loss at FDA (A), James G. Dickinson (MDDI, Jan 1990, p. 22). Keywords: Political Influence, Personnel.
  • News: Proposition 65 takes aim at medical device manufacturers (MDDI, Jan 1990, p. 18). Keywords: California, Proposition65.
  • Challenges for the next decade, Kshitij Mohan (MDDI, Jan 1990, p. 10). Keywords: Legislation, Regulatory Climate.
Return to the top of the page

1989

  • Washington Wrap-up: Hurrying up FDA, Larry Oster (MDDI, Dec 1989, p. 32). Keywords: Ob/Gyn Devices, Standards, Labeling.
  • Washington Wrap-up: FDA politicization, Larry Oster (MDDI, Dec 1989, p. 31). Keywords: Political Influence, Personnel.
  • Washington Wrap-up: Dingell on the warpath, Larry Oster (MDDI, Dec 1989, p. 28). Keywords: Government Criticism.
  • Sheridan shows imagination, competence, William D. Appler (MDDI, Dec 1989, p. 22). Keywords: Product Approval, Government-Industry Cooperation.
  • CFC control: more than air conditioners and styrofoam cups, Robert R. Reich (MDDI, Dec 1989, p. 10). Keyword: CFCs.
  • Washington Wrap-up: Approval with training, Larry Oster (MDDI, Nov 1989, p. 45). Keywords: Ob/Gyn Devices, Advisory Panels, Product Approval.
  • Washington Wrap-up: New FDA (A), Larry Oster (MDDI, Nov 1989, p. 42). Keywords: Safe Medical Devices Act, Political Influence, Regulatory Climate.
  • 1989 Waxman-Dingell medical devices bill (The), Howard M. Holstein (MDDI, Nov 1989, p. 34). Keywords: Safe Medical Devices Act, Legislation.
  • Will repercussions from generic drugs affect CDRH decision making?, William D. Appler (MDDI, Nov 1989, p. 22). Keywords: CDRH, Product Approval, Personnel.
  • Take no prisoners, Cheryl Doriot (MDDI, Nov 1989, p. 8). Keywords: Government Criticism, Industry Opinion.
  • FDA regulation of device-drug combinations, Jonathan S. Kahan (MDDI, Oct 1989, p. 58). Keywords: Combination Products.
  • Quality control in IVD manufacturing, Andrew J. O'Beirne (MDDI, Oct 1989, p. 52). Keywords: Quality, Manufacturing, QA/QC.
  • Washington Wrap-up: Clark Research loses again, Larry Oster (MDDI, Oct 1989, p. 49). Keywords: FDAEnforcement, Product Approval.
  • Washington Wrap-up: FDA plant registration fees?, Larry Oster (MDDI, Oct 1989, p. 48). Keywords: Legislation, Registration.
  • Washington Wrap-up: All eyes on Europe, Larry Oster (MDDI, Oct 1989, p. 46). Keywords: Standards, International Affairs.
  • Market Report: Business health-care costs up 30% in 1988, Pieter Halter (MDDI, Oct 1989, p. 42). Keywords: Insurance, Cost Containment.
  • FDA Notes: Elsewhere in court, William D. Appler (MDDI, Oct 1989, p. 37). Keywords: Regulatory Letter.
  • FDA Notes: Notes from the courthouse, William D. Appler (MDDI, Oct 1989, p. 36). Keyword: Inspections.
  • Non-FDA factors affecting entry into the device market, William D. Appler (MDDI, Oct 1989, p. 30). Keywords: Cost Containment, Reimbursement.
  • Waxman is back, Cheryl Doriot (MDDI, Oct 1989, p. 8). Keywords: Safe Medical Devices Act, Industry Opinion.
  • IRB Q&A, Samuel Herman (MDDI, Sep 1989, p. 90). Keywords: Significant Risk, HCFA, Clinical Investigations.
  • Washington Wrap-up: HRG grist for the mill, Larry Oster (MDDI, Sep 1989, p. 41). Keywords: FDAEnforcement, HRG, MDR.
  • Washington Wrap-up: Diagnosis proficiency testing, Larry Oster (MDDI, Sep 1989, p. 41). Keyword: Laboratories.
  • Washington Wrap-up: FDA standards compromise, Larry Oster (MDDI, Sep 1989, p. 40). Keywords: Ob/Gyn Devices, Labeling.
  • Washington Wrap-up: FDA device scandal? (An), Larry Oster (MDDI, Sep 1989, p. 38). Keywords: Government Criticism, Personnel.
  • Designing for 1992, Cheryl Doriot (MDDI, Sep 1989, p. 8). Keywords: Quality, Standards, Certification.
  • Working successfully with FDA, Jonathan S. Kahan (MDDI, Aug 1989, p. 42). Keywords: Regulatory Affairs, Compliance, Product Approval.
  • Washington Wrap-up: Medical waste, Larry Oster (MDDI, Aug 1989, p. 40). Keywords: Medical Waste.
  • Washington Wrap-up: Us against them, part I, Larry Oster (MDDI, Aug 1989, p. 34). Keyword: FDAEnforcement.
  • Washington Wrap-up: National health insurance, Larry Oster (MDDI, Aug 1989, p. 34). Keywords: Insurance Coverage.
  • Brave new world: a revolution is brewing, Nicholas A. Gallo (MDDI, Aug 1989, p. 12). Keywords: Cost Containment, Reimbursement.
  • User fees: debate continues, Cheryl Doriot (MDDI, Aug 1989, p. 8). Keywords: User Fees.
  • IRB Q&A, Samuel Herman (MDDI, Jul 1989, p. 48). Keywords: IRBs, Clinical Investigations.
  • Clinical Laboratory Improvement Amendments: trouble or opportunity for manufacturers?, Miles Weiss (MDDI, Jul 1989, p. 37). Keywords: CLIA88, Laboratories.
  • Washington Wrap-up: More on cost/benefit, Larry Oster (MDDI, Jul 1989, p. 28). Keywords: HRG, Product Approval, Home Testing.
  • Washington Wrap-up: User fees again, Larry Oster (MDDI, Jul 1989, p. 26). Keywords: User Fees.
  • GAO raises serious questions, William D. Appler (MDDI, Jul 1989, p. 20). Keywords: MDR, Government Criticism.
  • GAO's MDR report: few surprises, Cheryl Doriot (MDDI, Jul 1989, p. 8). Keyword: MDR.
  • Clinical Research Q&A, Maria M. Koretz (MDDI, Jun 1989, p. 160). Keywords: Efficacy, Product Positioning, Clinical Investigations.
  • Auditing by variables analysis: foiling Murphy's Law, Frank M. Gregorio (MDDI, Jun 1989, p. 108). Keywords: Audits, Variables Analysis.
  • Medical device investigations: understanding IRB and informed consent requirements, Jeffrey N. Gibbs (MDDI, Jun 1989, p. 103). Keywords: IRBs, Informed Consent, Clinical Investigations.
  • FDA: 10 years in retrospect, Larry Oster (MDDI, Jun 1989, p. 95). Keywords: FDAEnforcement, Organization, Assistance.
  • Washington Wrap-up: New laser catheter, Larry Oster (MDDI, Jun 1989, p. 68). Keyword: Lasers.
  • Washington Wrap-up: Fewer dental x-rays, Larry Oster (MDDI, Jun 1989, p. 68). Keyword: X-Rays.
  • Washington Wrap-up: Stun guns are devices, Larry Oster (MDDI, Jun 1989, p. 67). Keywords: Stun Guns.
  • Washington Wrap-up: Cost-effective devices, Larry Oster (MDDI, Jun 1989, p. 64). Keywords: Cost Containment, Advisory Panels, Product Approval.
  • Where have all the new regulations gone?, Mika O. Reinikainen (MDDI, Jun 1989, p. 46). Keywords: Harmonization, European Regulations, International Affairs.
  • Home-use AIDS tests: FDA's dilemma, William D. Appler (MDDI, Jun 1989, p. 36). Keywords: AIDS, Home Testing.
  • Statistical presentations for FDA submissions, Steven S. Lewis (MDDI, May 1989, p. 66). Keywords: Documentation, Premarket Approvals, Clinical Investigations.
  • FDA regulation of in vitro diagnostic devices, Jonathan S. Kahan (MDDI, May 1989, p. 41). Keywords: Diagnostics, Home Testing.
  • Washington Wrap-up: 'Intended' use, Larry Oster (MDDI, May 1989, p. 32). Keywords: FDAEnforcement, Classification.
  • Washington Wrap-up: 'Gotcha!' syndrome (The), Larry Oster (MDDI, May 1989, p. 26). Keywords: FDAEnforcement, 510(k)s.
  • FDA inspections: advanced strategies, William D. Appler (MDDI, May 1989, p. 18). Keywords: FDAEnforcement, Inspections.
  • Washington Wrap-up: Transition blues, Larry Oster (MDDI, Apr 1989, p. 110). Keywords: Political Influence, Personnel.
  • Clinical Research Q&A, Maria M. Koretz (MDDI, Apr 1989, p. 98). Keywords: Training, Clinical Investigations, Home Testing.
  • Washington Wrap-up: Case against user fees (The), Larry Oster (MDDI, Apr 1989, p. 36). Keywords: User Fees.
  • HCFA proposes new regulation for Medicare coverage of new technologies, Gordon B. Schatz (MDDI, Apr 1989, p. 30). Keyword: Reimbursement.
  • Benefits of an FDA/academic/industry partnership (The), William D. Appler (MDDI, Apr 1989, p. 22). Keywords: District Offices, Biotechnology, Government-Industry Cooperation.
  • American and European standards: the crossroads, John Anderson (MDDI, Apr 1989, p. 14). Keywords: Harmonization, Standards, European.
  • HCFA's rising influence, Cheryl Doriot (MDDI, Apr 1989, p. 8). Keyword: HCFA.
  • Recall: a second chance, Leonard J. Stauffer (MDDI, Mar 1989, p. 60). Keyword: Recalls.
  • Washington Wrap-up: Biotech AIDS kit, Larry Oster (MDDI, Mar 1989, p. 34). Keywords: Diagnostics, AIDS, Biotechnology.
  • Washington Wrap-up: 'Device' or a 'novelty'? (A), Larry Oster (MDDI, Mar 1989, p. 33). Keywords: Contraceptives, Classification.
  • Washington Wrap-up: Back to basics, Larry Oster (MDDI, Mar 1989, p. 33). Keyword: Compliance.
  • Washington Wrap-up: Happy IVD ending (A), Larry Oster (MDDI, Mar 1989, p. 33). Keyword: Inspections.
  • Washington Wrap-up: Hatch on devices, Larry Oster (MDDI, Mar 1989, p. 32). Keywords: Political Influence, Legislation, Contact Lens.
  • Case of EUCOMED (The), Mika O. Reinikainen (MDDI, Mar 1989, p. 24). Keywords: EUCOMED, Harmonization, European Regulations.
  • Assisting the FDA-regulated device industry: the ins and outs, William D. Appler (MDDI, Mar 1989, p. 16). Keywords: Compliance, Consultants, Assistance.
  • FDA classifies last device group, Arthur C. Kohler (MDDI, Feb 1989, p. 37). Keyword: Classification.
  • Washington Wrap-up: Home-use IVDs, Larry Oster (MDDI, Feb 1989, p. 25). Keywords: Diagnostics, Home Testing.
  • Washington Wrap-up: More efficient FDA (A), Larry Oster (MDDI, Feb 1989, p. 22). Keywords: Organization, Government-Industry Cooperation.
  • Rationality and FDA litigation, William D. Appler (MDDI, Feb 1989, p. 16). Keyword: FDAEnforcement.
  • Washington Wrap-up: Reuse of dialyzers, Larry Oster (MDDI, Jan 1989, p. 117). Keywords: Blood Devices, Reuse.
  • Proposition 65: the straw that breaks the camel's back?, Gary M. Stephenson (MDDI, Jan 1989, p. 62). Keywords: California, Proposition65, Regulatory Climate.
  • 510(k) notice and device software (The): what is required?, Jonathan S. Kahan (MDDI, Jan 1989, p. 57). Keywords: Software, 510(k)s.
  • Washington Wrap-up: Smokeless device, Larry Oster (MDDI, Jan 1989, p. 43). Keywords: Smokeless Cigarettes.
  • Washington Wrap-up: Quality of care ascendant, Larry Oster (MDDI, Jan 1989, p. 42). Keyword: Quality.
  • Medical plastics: the state of the industry, Jeffrey R. Ellis (MDDI, Jan 1989, p. 32). Keywords: Trends, Medical Waste.
  • Exporting reprocessed pacemakers: lessons learned and unresolved, William D. Appler (MDDI, Jan 1989, p. 26). Keywords: Reuse, Exports.
  • Mohan on more money for FDA, the deficit, agency predictability, Larry Oster (MDDI, Jan 1989, p. 20). Keywords: Budget Cuts, Product Approval, Industry Opinion.
  • Prop 65: debate continues, Cheryl Doriot (MDDI, Jan 1989, p. 8). Keywords: California, Proposition65.
Return to the top of the page

1988

  • Washington Wrap-up: Mohan leaves FDA, Larry Oster (MDDI, Dec 1988, p. 20). Keywords: Mohan, Personnel, Product Approval.
  • FDA's 'object all sublime': protecting public health, Kshitij Mohan (MDDI, Dec 1988, p. 10). Keywords: Consumer Affairs, Industry Opinion, Product Approval.
  • Washington Wrap-up: Home-care costs going up, Larry Oster (MDDI, Nov 1988, p. 88). Keywords: Cost Containment.
  • FDA approves three new products, Miles Weiss (MDDI, Nov 1988, p. 62). Keywords: Ultrasound, Premarket Approvals, Cardiovascular Devices.
  • Washington Wrap-up: Devices that need drugs, Larry Oster (MDDI, Nov 1988, p. 44). Keywords: Combination Products.
  • Washington Wrap-up: Laboratory quality controls, Larry Oster (MDDI, Nov 1988, p. 44). Keyword: Laboratories.
  • News: Latex condoms and accessories: summary of U.S. medical device requirements, Richard Rivera (MDDI, Nov 1988, p. 36). Keyword: Contraceptives.
  • News: Report calls for openness in Medicare coverage process (MDDI, Nov 1988, p. 29). Keyword: Medicare.
  • News: Proposed IOL rule meets opposition (MDDI, Nov 1988, p. 28). Keywords: Reimbursement, Intraocular Lens.
  • News: Proposed postal regulation draws industry response (MDDI, Nov 1988, p. 26). Keywords: Diagnostics, Biologics, Etiological Agents.
  • CFCs: going, going..., Greg Freiherr (MDDI, Oct 1988, p. 37). Keywords: Environmental Impact, CFCs.
  • Washington Wrap-up: Commissionerial patronage for cholesterol test?, Larry Oster (MDDI, Oct 1988, p. 30). Keyword: Diagnostics.
  • Washington Wrap-up: Mohan reports approval 'bad news', Larry Oster (MDDI, Oct 1988, p. 30). Keywords: Product Approval.
  • Washington Wrap-up: IVD guidelines, Larry Oster (MDDI, Oct 1988, p. 28). Keyword: Diagnostics.
  • Washington Wrap-up: GMP paper problems, Larry Oster (MDDI, Oct 1988, p. 28). Keywords: Compliance, GMPs.
  • Washington Wrap-up: FDA reclassifications, Larry Oster (MDDI, Oct 1988, p. 28). Keyword: Reclassification.
  • 1992 in perspective, Mika O. Reinikainen (MDDI, Oct 1988, p. 24). Keywords: Europe, EC92, European Regulations.
  • News: Task groups make recommendations, David Haut (MDDI, Oct 1988, p. 20). Keyword: Software.
  • News: Manufacturers take assertive role, David Haut (MDDI, Oct 1988, p. 17). Keyword: Reimbursement.
  • News: Device bill passes House, David Haut (MDDI, Oct 1988, p. 16). Keyword: Legislation.
  • Washington Wrap-up: Consolidating FDA, Larry Oster (MDDI, Sep 1988, p. 40). Keywords: Legislation, Organization.
  • Washington Wrap-up: Laboratory bill, Larry Oster (MDDI, Sep 1988, p. 40). Keyword: Laboratories.
  • Washington Wrap-up: Tampon ratings, Larry Oster (MDDI, Sep 1988, p. 38). Keywords: Ob/Gyn Devices.
  • Washington Wrap-up: Reclassification woes, Larry Oster (MDDI, Sep 1988, p. 38). Keyword: Reclassification.
  • Washington Wrap-up: Device legislation, Larry Oster (MDDI, Sep 1988, p. 38). Keyword: Legislation.
  • News: HCFA stalls payment for hemodialyzer bloodlines, David Haut (MDDI, Sep 1988, p. 32). Keywords: Reimbursement, Blood Devices.
  • News: FDA considers glove guidelines, David Haut (MDDI, Sep 1988, p. 30). Keywords: Gloves, Guidelines.
  • News: Liability case troubles industry, David Haut (MDDI, Sep 1988, p. 28). Keywords: Product Liability.
  • Campaign '88: interviews with the candidates' health policy advisors, David Haut (MDDI, Sep 1988, p. 18). Keywords: Political Influence, Legislation.
  • Washington Wrap-up: Medicare changes, Larry Oster (MDDI, Aug 1988, p. 28). Keywords: Medicare, Legislation.
  • Anatomy of an EEC Directive, Mika O. Reinikainen (MDDI, Aug 1988, p. 24). Keywords: Electronic Devices, Harmonization, European Regulations.
  • News: Policy inches forward, David Haut (MDDI, Aug 1988, p. 23). Keyword: Software.
  • News: Proposition 65; gray areas persist, David Haut (MDDI, Aug 1988, p. 21). Keyword: Proposition65.
  • News: Design transfer: regulatory trouble ahead?, David Haut (MDDI, Aug 1988, p. 20). Keywords: Preproduction QA, Design Transfer.
  • News: HCFA holds financial line, David Haut (MDDI, Aug 1988, p. 18). Keywords: Cost Containment, Reimbursement.
  • Washington Wrap-up: Post-mortem on BioClinical case, Larry Oster (MDDI, Jul 1988, p. 24). Keyword: FDAEnforcement.
  • Washington Wrap-up: Automatic detention of imports, Larry Oster (MDDI, Jul 1988, p. 24). Keywords: FDAEnforcement, Imports.
  • Washington Wrap-up: Other CDRH accomplishments, Larry Oster (MDDI, Jul 1988, p. 22). Keywords: Management, Risk Assessment.
  • News: Industry unsettled over guideline, David Haut (MDDI, Jul 1988, p. 20). Keyword: Software.
  • News: Trade bill's future unclear, David Haut (MDDI, Jul 1988, p. 20). Keywords: Legislation, Exports.
  • News: FDA blocks home AIDS tests, David Haut (MDDI, Jul 1988, p. 19). Keywords: AIDS, Home Testing.
  • News: Proposition 65: is it spreading?, David Haut (MDDI, Jul 1988, p. 18). Keyword: Proposition65.
  • News: CFC production limit: too little too late?, David Haut (MDDI, Jul 1988, p. 16). Keyword: CFCs.
  • News: FDA categorizes preproduction recalls, David Haut (MDDI, Jul 1988, p. 16). Keywords: Preproduction QA, Recalls.
  • Industry reps: up from second-class citizenship: an interview with Amiram Daniel, PhD, Director of Diagnostic Manufacturing and Biotechnology Programs, HIMA, David Haut (MDDI, Jul 1988, p. 14). Keywords: Advisory Panels, Government-Industry Cooperation.
  • Making device regulation work, Frank E. Samuel, Jr. (MDDI, Jul 1988, p. 10). Keywords: Industry Opinion.
  • Clinical Research Q&A, Maria M. Koretz (MDDI, Jun 1988, p. 150). Keywords: IRBs, Informed Consent, Clinical Investigations.
  • Guilty: home-use IVDs: avoiding liability, Jonathan S. Kahan (MDDI, Jun 1988, p. 65). Keywords: Diagnostics, Product Liability.
  • Washington Wrap-up: Industry innovation, Larry Oster (MDDI, Jun 1988, p. 46). Keywords: Diagnostics, Product Approval.
  • Washington Wrap-up: GMP emphasis shifts, Larry Oster (MDDI, Jun 1988, p. 46). Keywords: Diagnostics, Guidelines.
  • Washington Wrap-up: When government abuses, Larry Oster (MDDI, Jun 1988, p. 44). Keywords: Diagnostics, FDAEnforcement.
  • News: FDA tissue regulation slow in coming, Jonathan S. Kahan (MDDI, Jun 1988, p. 34). Keywords: Transplant Tissue.
  • News: Biotech trade concerns voiced, Bruce F. Mackler (MDDI, Jun 1988, p. 33). Keywords: Exports, Biotechnology.
  • News: HCFA to publish Medicare coverage criteria, David Haut (MDDI, Jun 1988, p. 32). Keywords: HCFA, Medicare, Reimbursement.
  • News: Caveat importer, John F. Stigi (MDDI, Jun 1988, p. 31). Keywords: Gloves, Imports.
  • News: OSMA critical of new list, David Haut (MDDI, Jun 1988, p. 29). Keywords: Critical Devices.
  • News: OSHA issues excursion limit, David Haut (MDDI, Jun 1988, p. 28). Keywords: Et O, Occupational Safety.
  • News: Preproduction QA given high priority, David Haut (MDDI, Jun 1988, p. 28). Keywords: Preproduction QA, Quality.
  • International competition: a blueprint for action, Anthony G. Aiuvalasit, Jr. (MDDI, Jun 1988, p. 24). Keywords: Exports, International Regulations.
  • Rare oppportunity (A), David M. Link (MDDI, Jun 1988, p. 22). Keyword: Quality.
  • News: Industry responds to Proposition 65 requirements (MDDI, May 1988, p. 47). Keyword: Proposition65.
  • News: AIDS policy: will the health-care industry take the lead? (MDDI, May 1988, p. 42). Keywords: AIDS, Personnel.
  • Washington Wrap-up: 'Action Plan' fruits, Larry Oster (MDDI, May 1988, p. 15). Keywords: Classification, Radiology Devices.
  • News: Antimicrobial plastic devices: is commercialization imminent? (MDDI, Apr 1988, p. 92). Keywords: Technology Transfer, Commercialization.
  • News: Proposition 65 warning regulations issued (MDDI, Apr 1988, p. 91). Keywords: California, Proposition65.
  • Washington Wrap-up: Repercussions on Capitol Hill and beyond, Larry Oster (MDDI, Apr 1988, p. 18). Keywords: Government Criticism, District Offices.
  • Washington Wrap-up: Experts disagree, Larry Oster (MDDI, Apr 1988, p. 16). Keywords: FDAEnforcement, Compliance.
  • Washington Wrap-up: More about BioClinical, Larry Oster (MDDI, Apr 1988, p. 14). Keywords: FDAEnforcement, Compliance.
  • News: Health Care Innovation Act lies comatose (MDDI, Mar 1988, p. 50). Keywords: Medicare, Reimbursement, Innovation.
  • Determining differences between drugs and devices, John F. Stigi (MDDI, Mar 1988, p. 42). Keywords: Terminology, Classification.
  • Washington Wrap-up: FDLI: a clarification, Larry Oster (MDDI, Mar 1988, p. 13). Keyword: FDLI.
  • Washington Wrap-up: HIMA's ambitions for FDA, Larry Oster (MDDI, Mar 1988, p. 12). Keywords: Industry Opinion.
  • Washington Wrap-up: No resting on its laurels for CDRH, Larry Oster (MDDI, Mar 1988, p. 10). Keywords: CDRH, Product Approval.
  • Washington Wrap-up: Will there be a law?, Larry Oster (MDDI, Mar 1988, p. 10). Keyword: Legislation.
  • Toward a quality outcome for 1988, Daniel E. Gill (MDDI, Mar 1988, p. 8). Keyword: Quality.
  • News: Exporting medical devices to West Germany (MDDI, Feb 1988, p. 52). Keywords: International Affairs, Exports.
  • News: ASTM panel surveying hospital reuse patterns (MDDI, Feb 1988, p. 50). Keyword: Reuse.
  • News: EPA issues CFC proposal; action on EtO imminent (MDDI, Feb 1988, p. 48). Keywords: Et O, EPA, CFCs.
  • Profile of IDE applications, Carl F. Blozan (MDDI, Feb 1988, p. 42). Keyword: IDEs.
  • Biotechnology Dialogue: California Proposition 65 update, Bruce F. Mackler (MDDI, Feb 1988, p. 28). Keyword: Proposition65.
  • Biotechnology Dialogue: United States signs free trade agreement with Canada, Bruce F. Mackler (MDDI, Feb 1988, p. 26). Keywords: International Trade.
  • Washington Wrap-up: Focus on quality (A), Larry Oster (MDDI, Feb 1988, p. 16). Keyword: Quality.
  • Guidelines aren't regulations (and other lessons from the federal courts), William D. Appler (MDDI, Feb 1988, p. 10). Keywords: FDAEnforcement, Guidelines.
  • News: FDA seizure of explanted pacemakers stirs controversy (MDDI, Jan 1988, p. 121). Keywords: Product Seizures, Reuse, Exports.
  • News: CITEHC: a boon or a bane to industry? (MDDI, Jan 1988, p. 120). Keywords: CITEHC, Standards Setting, Standards.
  • News: Pending legislation offers limited help for orphan device development (MDDI, Jan 1988, p. 118). Keywords: Legislation, Orphan Devices.
  • What's ahead for 1988?: thoughts on priorities and strategies for the coming year (MDDI, Jan 1988, p. 50). Keyword: Forecasts.
  • Season of conferences and revelations (A), Mika O. Reinikainen (MDDI, Jan 1988, p. 24). Keywords: European Regulations, International Affairs.
  • Washington Wrap-up: 'Orphan device' defined; incentives sought, Larry Oster (MDDI, Jan 1988, p. 16). Keywords: Orphan Devices.
  • Washington Wrap-up: Quality-of-care reemerges as a primary goal, Larry Oster (MDDI, Jan 1988, p. 15). Keywords: Long-Term Care.
  • Washington Wrap-up: Will unfettered competition be allowed to continue?, Larry Oster (MDDI, Jan 1988, p. 14). Keywords: Regulatory Climate.
  • FDA's software policy: troubling implications, Edward M. Basile (MDDI, Jan 1988, p. 10). Keyword: Software.
Return to the top of the page

1987

  • Washington Wrap-up: Novel use of the petition process (A), Larry Oster (MDDI, Dec 1987, p. 14). Keyword: Labeling.
  • Washington Wrap-up: Software policy: deregulation lives, Larry Oster (MDDI, Dec 1987, p. 12). Keywords: Software, Deregulation.
  • Washington Wrap-up: Legislation moving again?, Larry Oster (MDDI, Dec 1987, p. 12). Keyword: Legislation.
  • Washington Wrap-up: No more backlogs!, Larry Oster (MDDI, Dec 1987, p. 10). Keywords: CDRH, Product Approval.
  • Washington Wrap-up: CDRH accused of slowness, Larry Oster (MDDI, Nov 1987, p. 72). Keywords: Ob/Gyn Devices, Cardiovascular Devices.
  • Washington Wrap-up: FDA 'politicization', Larry Oster (MDDI, Nov 1987, p. 72). Keywords: Political Influence.
  • Minimizing product liability exposure in device labeling, Bruce F. Mackler (MDDI, Nov 1987, p. 28). Keywords: Product Liability, Labeling.
  • Proposition 65: not a scary beast, David Roe (MDDI, Nov 1987, p. 24). Keyword: Proposition65.
  • Washington Wrap-up: Cleaning out 510(k) waste, Larry Oster (MDDI, Nov 1987, p. 16). Keywords: Deregulation, 510(k)s.
  • Washington Wrap-up: New FDA rules for health fraud, Larry Oster (MDDI, Nov 1987, p. 15). Keywords: Health Fraud.
  • Washington Wrap-up: Are FDA's centers too secretive?, Larry Oster (MDDI, Nov 1987, p. 15). Keywords: Government Relations.
  • Washington Wrap-up: Scant comfort in FOI changes, Larry Oster (MDDI, Nov 1987, p. 14). Keyword: FOI.
  • Medical devices: an atypical regulatory climate?, Gerard J. Griesmer (MDDI, Nov 1987, p. 10). Keywords: Environmental Impact, Safety, Regulatory Climate.
  • Washington Wrap-up: Contact lens cleaner problems, revisited, Larry Oster (MDDI, Oct 1987, p. 18). Keywords: Contact Lens.
  • Washington Wrap-up: Suntanning controversy pits federal versus town law, Larry Oster (MDDI, Oct 1987, p. 18). Keyword: Sunlamp.
  • Washington Wrap-up: Color-safety challenge ahead?, Larry Oster (MDDI, Oct 1987, p. 14). Keywords: Color Additives.
  • Washington Wrap-up: Less advice, more speed?, Larry Oster (MDDI, Oct 1987, p. 14). Keywords: Advisory Panels, Product Approval.
  • Preproduction quality assurance: no surprise, James W. Hartman (MDDI, Oct 1987, p. 10). Keywords: Preproduction QA, Design Review.
  • Final PMA regulations (The): ten months later, Jonathan S. Kahan (MDDI, Sep 1987, p. 46). Keywords: Premarket Approvals, Regulations, Product Approval.
  • FDA and dialyzer reuse: separating fact from fiction, Edmund G. Lowrie (MDDI, Sep 1987, p. 28). Keyword: Reuse.
  • Biotechnology Dialogue: German Drug Law update, Bruce F. Mackler (MDDI, Sep 1987, p. 25). Keywords: Germany, International Affairs.
  • Biotechnology Dialogue: Word processing approach to expedite PMAs revisited, Bruce F. Mackler (MDDI, Sep 1987, p. 24). Keywords: Product Approval.
  • Biotechnology Dialogue: EPA proposes toxic chemical rule, Bruce F. Mackler (MDDI, Sep 1987, p. 22). Keywords: Environmental Impact, Hazardous Waste, EPA.
  • Biotechnology Dialogue: FDA issues 'Points to Consider' that affects monoclonal antibody products, Bruce F. Mackler (MDDI, Sep 1987, p. 22). Keywords: Biologics, Points To Consider.
  • Biotechnology Dialogue: FDA GMP inspectional guidelines found unenforceable, Bruce F. Mackler (MDDI, Sep 1987, p. 22). Keywords: Guidelines, FDAEnforcement.
  • Washington Wrap-up: OMB altering one rule in four, Larry Oster (MDDI, Sep 1987, p. 21). Keywords: Political Influence.
  • Washington Wrap-up: Senate considers levying annual fees on approved devices, Larry Oster (MDDI, Sep 1987, p. 21). Keywords: User Fees.
  • Washington Wrap-up: CDRH to lead new risk assessment program, Larry Oster (MDDI, Sep 1987, p. 20). Keywords: Risk Assessment.
  • Washington Wrap-up: Full speed ahead for new device law, Larry Oster (MDDI, Sep 1987, p. 18). Keywords: Legislation, Product Approval.
  • Medical devices and regulatory letters: an analysis of FDA enforcement actions, Jeffrey N. Gibbs (MDDI, Aug 1987, p. 42). Keywords: FDAEnforcement, GMPs.
  • California's Proposition 65: labeling requirements ahead?, Gary Yingling (MDDI, Aug 1987, p. 34). Keywords: Environmental Impact, Proposition65, Hazardous Waste.
  • Washington Wrap-up: MDR extended, piecemeal, Larry Oster (MDDI, Aug 1987, p. 18). Keyword: MDR.
  • Washington Wrap-up: Preproduction QA guide issued, Larry Oster (MDDI, Aug 1987, p. 18). Keywords: Guidelines, Quality.
  • Washington Wrap-up: FDA chief a presidential appointee?, Larry Oster (MDDI, Aug 1987, p. 16). Keywords: Political Influence, Management.
  • Washington Wrap-up: New device legislation inevitable, Larry Oster (MDDI, Aug 1987, p. 14). Keywords: Legislation, Regulatory Climate, Product Approval.
  • Sterile packaging: what can we expect from FDA?, Joseph D. O'Brien (MDDI, Aug 1987, p. 10). Keywords: Sterilization, Testing.
  • Medical product sterilization: changes and challenges, James F. Jorkasky (MDDI, Jul 1987, p. 32). Keywords: Environmental Impact, Sterilization, Safety.
  • Washington Wrap-up: FOI setback (An), Larry Oster (MDDI, Jul 1987, p. 12). Keyword: FOI.
  • Washington Wrap-up: Turning up the heat, Larry Oster (MDDI, Jul 1987, p. 10). Keywords: Cost Containment, Political Influence.
  • Beyond FDA: coverage and payment hurdles, B. Kristine Johnson (MDDI, Jul 1987, p. 8). Keywords: DRGs, Reimbursement, Technology Assessment.
  • Determining 'increased frequency' under the MDR rule, Bogdan Dziurzynski (MDDI, Jun 1987, p. 92). Keyword: MDR.
  • MDR inspections: what to expect and how to prepare, Edward M. Basile (MDDI, Jun 1987, p. 84). Keywords: Compliance, MDR, Inspections.
  • CDRH's Jim Benson: Making systematic improvements in the product evaluation process, James S. Benson (MDDI, Jun 1987, p. 76). Keywords: Forecasts, Product Approval, Assistance.
  • High-priority devices: how are they chosen?, Harvey Rudolph (MDDI, Jun 1987, p. 64). Keywords: Problem Definition Study, Prioritization.
  • Critical devices: guilty until proven innocent?, Eldon E. Frisch (MDDI, Jun 1987, p. 52). Keywords: Advisory Committees, Critical Devices.
  • Biotechnology Dialogue: FDA addresses ABC convention, Bruce F. Mackler (MDDI, Jun 1987, p. 36). Keyword: Biotechnology.
  • Medical device regulation in the smaller European countries, Mika O. Reinikainen (MDDI, Jun 1987, p. 28). Keywords: International Affairs, European Regulations.
  • Washington Wrap-up: Easing tort concerns, Larry Oster (MDDI, Jun 1987, p. 22). Keywords: Product Liability.
  • Washington Wrap-up: Welcoming user fees?, Larry Oster (MDDI, Jun 1987, p. 20). Keywords: User Fees.
  • Washington Wrap-up: Upgrades for MDR analysis, Larry Oster (MDDI, Jun 1987, p. 20). Keyword: MDR.
  • Device regulation: oversight, not legislative reform, Larry R. Pilot (MDDI, Jun 1987, p. 12). Keywords: Legislation, Amendments.
  • Biotechnology Dialogue: Worldwide patent harmonization necessary to prevent discrimination, Bruce F. Mackler (MDDI, May 1987, p. 29). Keywords: International Affairs, Biotechnology, Patents.
  • Biotechnology Dialogue: FDA developing 510(k) guidance manual, Bruce F. Mackler (MDDI, May 1987, p. 28). Keywords: Manuals, 510(k)s, Biotechnology.
  • Biotechnology Dialogue: FDA considering diskette submission to expedite PMA negotiations., Bruce F. Mackler (MDDI, May 1987, p. 26). Keywords: Package Inserts, Product Approval.
  • SMA News: Questions most often asked of DSMA (MDDI, May 1987, p. 22). Keywords: Amendments, Regulations, Product Approval.
  • Washington Wrap-up: Investigator compensation bill, Larry Oster (MDDI, May 1987, p. 12). Keywords: Commercialization, Clinical Investigations.
  • Washington Wrap-up: ECT survivors show skill, Larry Oster (MDDI, May 1987, p. 12). Keywords: Electroconvulsive Therapy, Reclassification.
  • Washington Wrap-up: Inspectors with cameras, Larry Oster (MDDI, May 1987, p. 10). Keyword: Inspections.
  • Washington Wrap-up: Secretarial reclassification?, Larry Oster (MDDI, May 1987, p. 10). Keyword: Reclassification.
  • Reuse: once more, with emphasis, Edward R. Duffie, Jr. (MDDI, May 1987, p. 8). Keywords: Product Liability, Reuse.
  • Return of the STEL (The), Timothy A. Rice (MDDI, Apr 1987, p. 24). Keywords: OSHA, Safety, Et OResiduals.
  • Washington Wrap-up: Boost of deregulation around the corner? (A), Larry Oster (MDDI, Apr 1987, p. 16). Keywords: Diagnostics, Deregulation.
  • Washington Wrap-up: Case in point (A), Larry Oster (MDDI, Apr 1987, p. 14). Keywords: Regulatory Climate.
  • Washington Wrap-up: Changes foreseen in the regulatory climate, Larry Oster (MDDI, Apr 1987, p. 14). Keywords: Regulatory Climate.
  • Validating computer systems, Jonathan S. Kahan (MDDI, Mar 1987, p. 48). Keywords: Validation, GMPs, Computer Systems.
  • Are you prepared for the FDA inspection?, Martha M. Bennett (MDDI, Mar 1987, p. 30). Keyword: Inspections.
  • Washington Wrap-up: Revision of IDE rules, Larry Oster (MDDI, Mar 1987, p. 24). Keywords: Commercialization, IDEs.
  • High motives in technology and health care, Karl D. Bays (MDDI, Mar 1987, p. 10). Keywords: Cost Containment, Industry Opinion.
  • SMA News: More case studies of device recalls (MDDI, Feb 1987, p. 53). Keyword: Recalls.
  • Biotechnology Dialogue: FDA sensitivities in evaluating immunological devices, Bruce F. Mackler (MDDI, Feb 1987, p. 25). Keyword: Biotechnology.
  • Biotechnology Dialogue: PMA environmental-impact considerations, Bruce F. Mackler (MDDI, Feb 1987, p. 24). Keywords: Environmental Impact, Premarket Approvals.
  • Washington Wrap-up: He's a bureaucrat, too, Larry Oster (MDDI, Feb 1987, p. 18). Keyword: 510(k)s.
  • Washington Wrap-up: Mohan revolution (The), Larry Oster (MDDI, Feb 1987, p. 18). Keywords: Product Approval.
  • Washington Wrap-up: New FOI charges to be assessed, Larry Oster (MDDI, Feb 1987, p. 16). Keyword: FOI.
  • Washington Wrap-up: Quality of care looms, Larry Oster (MDDI, Feb 1987, p. 16). Keywords: Cost Containment.
  • Washington Wrap-up: Brighter outlook (A), Larry Oster (MDDI, Feb 1987, p. 14). Keywords: Political Influence, Reimbursement.
  • FR Update: Federal Register citations: April-September 1986, Martin Friedman (MDDI, Jan 1987, p. 100). Keywords: Federal Register.
  • HR 5516: viewpoints on the Medical Device Improvement Act of 1986, Ted R. Mannen (MDDI, Jan 1987, p. 40). Keywords: Legislation, Industry Opinion.
  • Where goes Germany?, Mika O. Reinikainen (MDDI, Jan 1987, p. 28). Keywords: Germany, European Regulations.
  • Washington Wrap-up: Without controversy, would FDA act?, Larry Oster (MDDI, Jan 1987, p. 20). Keywords: Ob/Gyn Devices, Government Criticism.
  • Washington Wrap-up: End to FDA's regulatory-initiative recess (An), Larry Oster (MDDI, Jan 1987, p. 18). Keywords: Legislation, Regulatory Climate.
  • HR 5516: much-needed reform, Henry A. Waxman (MDDI, Jan 1987, p. 12). Keywords: Legislation, Product Approval.
Return to the top of the page

1986

  • Washington Wrap-up: 510(k) FOI crisis fades (The), Larry Oster (MDDI, Dec 1986, p. 23). Keyword: FOI.
  • Washington Wrap-up: New improvements unwelcome, Larry Oster (MDDI, Dec 1986, p. 18). Keywords: Legislation, Industry Opinion.
  • Washington Wrap-up: PMA regulations: a spirit of cooperation, Larry Oster (MDDI, Dec 1986, p. 16). Keywords: Premarket Approvals, Government-Industry Cooperation.
  • GMPAC: a perspective, Thomas